Nursing Essentials: A Comprehensive Clinical Textbook
A comprehensive clinical nursing textbook integrating detailed medical–surgical nursing, pathology, microbiology, pharmacology and paediatrics, with extended disease discussions, nursing management and medication-calculation principles.
Preface
Nursing Essentials: A Comprehensive Clinical Textbook was developed as a practical, system-based reference for nursing students and healthcare learners who need a clear bridge between basic sciences and clinical care.
The book integrates pathology, microbiology, pharmacology, paediatrics and medical–surgical nursing so that each condition can be understood from its underlying mechanism through assessment, investigation, treatment, nursing management and patient education.
Its emphasis is on clinically relevant knowledge, safe nursing practice, structured reasoning and application at the bedside, while encouraging readers to use current guidelines, recognised formularies and institutional protocols in clinical practice.
About This Textbook
Nursing Essentials: A Comprehensive Clinical Textbook is organised as a system-based nursing reference integrating medical–surgical nursing, pathology, microbiology, pharmacology and paediatrics. Every topic is explained in continuous textbook prose with clinical subheadings, nursing implications, key points and patient-safety considerations.
The pharmacology and paediatric medication sections emphasise safe nursing practice. Drug doses for real patients must always be verified against the current prescriber order, the patient’s age and weight, renal/hepatic function, allergies, a recognised paediatric formulary and institutional policy.
Major Parts
Part I — Medical–Surgical Nursing Part II — General & Systemic Pathology Part III — Clinical Microbiology & Infection Prevention Part IV — Pharmacology for Nurses Part V — Paediatric Nursing, Medicines & Drug CalculationsMedical–Surgical Nursing
Sixty-four clinical conditions organised by body system, with pathophysiology, assessment, investigations, medical treatment, nursing management, monitoring and patient education.
HYPERTENSION
Persistent elevation of arterial blood pressure. It is often asymptomatic but increases the risk of stroke, coronary disease, heart failure, kidney disease and retinopathy.
Persistent elevation of arterial blood pressure. It is often asymptomatic but increases the risk of stroke, coronary disease, heart failure, kidney disease and retinopathy.
Hypertension is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Primary hypertension is multifactorial; secondary causes include renal, endocrine, vascular and medication-related disorders.
- Risk rises with age, family history, excess sodium intake, obesity, inactivity, tobacco exposure and harmful alcohol use.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Blood pressure rises when cardiac output, systemic vascular resistance, or both remain chronically elevated. In primary hypertension, renal sodium handling, sympathetic nervous system activity, the renin–angiotensin–aldosterone system, vascular stiffness and endothelial dysfunction interact over time. Persistent pressure load causes left-ventricular hypertrophy and accelerates vascular injury in the brain, kidneys, retina and coronary arteries.
- Frequently no symptoms.
- Severe elevation may be associated with headache, visual disturbance, chest discomfort, dyspnoea or neurological symptoms.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Confirm with properly measured repeated blood pressure readings or ambulatory/home monitoring when appropriate. Assess urinalysis, renal function, electrolytes, glucose/HbA1c, lipids, ECG and evidence of target-organ damage.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Lifestyle measures plus antihypertensive therapy selected according to comorbidity, age, pregnancy status and guideline recommendations. Common classes include thiazide-like diuretics, ACE inhibitors/ARBs and calcium-channel blockers.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Use correct cuff size and technique; monitor trends and orthostatic symptoms; assess adherence and adverse effects; reinforce low-salt balanced diet, activity and weight management; teach home BP recording; escalate symptoms suggesting hypertensive emergency.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Persistent elevation of arterial blood pressure.
- It is often asymptomatic but increases the risk of stroke, coronary disease, heart failure, kidney disease and retinopathy.
- Monitor serial blood pressure using correct technique, orthostatic symptoms, renal function, potassium, treatment adherence and evidence of target-organ injury.
- Sudden neurological deficit, acute pulmonary oedema, chest pain, aortic-type pain or acute kidney injury with very high blood pressure suggests a hypertensive emergency rather than uncomplicated hypertension.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Secondary causes should be considered when hypertension is severe, abrupt in onset, resistant to treatment, occurs at an unusually young age, or is associated with suggestive clinical features. Important possibilities include renal parenchymal disease, renovascular disease, primary aldosteronism, thyroid disease, obstructive sleep apnoea, pheochromocytoma and medication- or substance-related hypertension. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor serial blood pressure using correct technique, orthostatic symptoms, renal function, potassium, treatment adherence and evidence of target-organ injury. Sudden neurological deficit, acute pulmonary oedema, chest pain, aortic-type pain or acute kidney injury with very high blood pressure suggests a hypertensive emergency rather than uncomplicated hypertension. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Stroke, myocardial infarction, heart failure, chronic kidney disease, aortic disease and hypertensive retinopathy.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
STABLE ANGINA
Predictable transient myocardial ischaemia, usually due to fixed atherosclerotic coronary narrowing, producing chest discomfort with exertion or stress and relief with rest or anti-anginal therapy.
Predictable transient myocardial ischaemia, usually due to fixed atherosclerotic coronary narrowing, producing chest discomfort with exertion or stress and relief with rest or anti-anginal therapy.
Stable Angina is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Atherosclerotic coronary artery disease is the usual cause.
- Risk factors include hypertension, dyslipidaemia, diabetes, tobacco exposure, age and family history.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Stable angina occurs when myocardial oxygen demand temporarily exceeds the oxygen supply available through a fixed atherosclerotic coronary narrowing. Exertion, cold exposure, tachycardia and emotional stress increase demand. Ischaemia alters myocardial metabolism and stimulates cardiac sensory fibres, producing the characteristic pressure or tightness that resolves when demand falls.
- Pressure, heaviness or tightness in the chest that may radiate to the arm, neck, jaw or back; often triggered by exertion, cold or emotional stress and relieved by rest.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical history, resting ECG, blood tests for cardiovascular risk, and non-invasive ischaemia testing or coronary imaging when indicated.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Risk-factor reduction, antiplatelet and lipid-lowering therapy when appropriate, anti-anginal medicines such as beta-blockers, calcium-channel blockers or nitrates, and revascularisation for selected patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain using PQRST; monitor vital signs and ECG if symptomatic; reduce activity during episodes; administer prescribed anti-anginal therapy and observe response; reinforce medication adherence and when to seek emergency help for new, prolonged or changing pain.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Predictable transient myocardial ischaemia, usually due to fixed atherosclerotic coronary narrowing, producing chest discomfort with exertion or stress and relief with rest or anti-anginal therapy.
- Document pain onset, quality, radiation, precipitating factors, duration and response to rest or prescribed medication.
- Monitor heart rate, blood pressure and ECG when symptomatic.
- Worsening frequency, lower exercise threshold or symptoms at rest require urgent reassessment.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Acute coronary syndrome must be excluded when pain is new, occurs at rest, is prolonged, is more severe than usual or has changed in pattern. Other important causes of chest pain include pulmonary embolism, aortic disease, pericarditis, gastro-oesophageal reflux and musculoskeletal pain. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Document pain onset, quality, radiation, precipitating factors, duration and response to rest or prescribed medication. Monitor heart rate, blood pressure and ECG when symptomatic. Worsening frequency, lower exercise threshold or symptoms at rest require urgent reassessment. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Acute coronary syndrome, myocardial infarction, arrhythmia, heart failure and sudden cardiac events.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE CORONARY SYNDROME / MYOCARDIAL INFARCTION
Acute myocardial ischaemia caused by sudden reduction in coronary blood flow. Myocardial infarction involves myocardial injury with a rise/fall in cardiac troponin in an ischaemic clinical context.
Acute myocardial ischaemia caused by sudden reduction in coronary blood flow. Myocardial infarction involves myocardial injury with a rise/fall in cardiac troponin in an ischaemic clinical context.
Acute Coronary Syndrome / Myocardial Infarction is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Most commonly rupture or erosion of an atherosclerotic plaque with thrombus formation; less commonly coronary spasm, embolism, spontaneous dissection or severe oxygen supply–demand imbalance.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Most acute coronary syndromes begin with disruption of an atherosclerotic plaque followed by platelet activation and thrombus formation. Partial occlusion may cause unstable angina or NSTEMI, while persistent complete occlusion commonly causes STEMI. Prolonged ischaemia produces irreversible cardiomyocyte necrosis, which releases cardiac troponin and can impair electrical stability and ventricular function.
- Central pressure-like chest pain or discomfort, diaphoresis, nausea, dyspnoea, weakness or atypical symptoms.
- Older adults and people with diabetes may have less typical presentations.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Immediate 12-lead ECG, serial high-sensitivity troponin, vital signs, blood tests and urgent assessment for reperfusion strategy when STEMI is suspected.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Time-critical emergency care may include antiplatelet therapy, anticoagulation, anti-ischaemic therapy, high-intensity lipid lowering and urgent PCI or fibrinolysis when indicated by the clinical setting and guideline.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Recognise and escalate immediately; obtain ECG promptly; maintain cardiac monitoring and IV access; assess pain, oxygen saturation and haemodynamic status; give prescribed emergency medicines; watch for arrhythmia, shock and heart failure; provide calm explanations and discharge education after stabilisation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute myocardial ischaemia caused by sudden reduction in coronary blood flow.
- Myocardial infarction involves myocardial injury with a rise/fall in cardiac troponin in an ischaemic clinical context.
- Continuous rhythm monitoring is important because malignant arrhythmias can occur early.
- Reassess pain, haemodynamics, oxygenation, mental state, urine output and signs of heart failure or shock.
- Recurrent chest pain, new ST-segment change, hypotension or pulmonary oedema requires immediate escalation.
- Reassessment should occur after every significant intervention and whenever symptoms change.
Life-threatening mimics include aortic dissection, pulmonary embolism, tension pneumothorax and severe oesophageal rupture. Pericarditis, myocarditis, pneumonia and gastrointestinal causes may also resemble ACS. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Continuous rhythm monitoring is important because malignant arrhythmias can occur early. Reassess pain, haemodynamics, oxygenation, mental state, urine output and signs of heart failure or shock. Recurrent chest pain, new ST-segment change, hypotension or pulmonary oedema requires immediate escalation. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Arrhythmias, cardiogenic shock, acute heart failure, mechanical complications, pericarditis and recurrent ischaemia.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HEART FAILURE
A clinical syndrome in which cardiac structural or functional abnormality impairs ventricular filling or ejection, causing symptoms such as breathlessness, fatigue and fluid retention.
A clinical syndrome in which cardiac structural or functional abnormality impairs ventricular filling or ejection, causing symptoms such as breathlessness, fatigue and fluid retention.
Heart Failure is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common causes include coronary artery disease, long-standing hypertension, valvular disease, cardiomyopathy and arrhythmia.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Heart failure develops when ventricular filling or ejection is impaired enough that the heart cannot meet metabolic needs without elevated filling pressures. Reduced systolic function lowers forward flow, whereas diastolic dysfunction reduces ventricular compliance. Neurohormonal activation initially preserves perfusion but promotes vasoconstriction, sodium retention, remodelling and further congestion.
- Dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, fatigue, ankle oedema, raised jugular venous pressure, pulmonary crackles and rapid weight gain from fluid retention.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
ECG, chest imaging when needed, natriuretic peptides, echocardiography, renal function, electrolytes, blood count, thyroid tests and assessment for the underlying cause.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Management may include diuretics for congestion and guideline-directed disease-modifying therapy such as ACE inhibitor/ARB/ARNI, evidence-based beta-blocker, mineralocorticoid receptor antagonist and SGLT2 inhibitor in appropriate patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Daily weight and fluid-balance monitoring; assess oedema, lung sounds, oxygenation and exercise tolerance; monitor renal function/electrolytes after therapy changes; reinforce sodium/fluid advice when prescribed; teach red flags such as rapid weight gain and worsening breathlessness.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- A clinical syndrome in which cardiac structural or functional abnormality impairs ventricular filling or ejection, causing symptoms such as breathlessness, fatigue and fluid retention.
- Daily weight, fluid balance, blood pressure, heart rate, oedema, lung sounds, oxygenation, renal function and electrolytes are essential.
- Rapid weight gain, increasing orthopnoea, new confusion, hypotension or worsening renal function can indicate decompensation.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Dyspnoea and oedema may also result from renal failure, liver disease, chronic lung disease, anaemia or venous disease. Acute deterioration may be triggered by infection, myocardial ischaemia, arrhythmia, uncontrolled hypertension, renal dysfunction or medication non-adherence. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Daily weight, fluid balance, blood pressure, heart rate, oedema, lung sounds, oxygenation, renal function and electrolytes are essential. Rapid weight gain, increasing orthopnoea, new confusion, hypotension or worsening renal function can indicate decompensation. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Pulmonary oedema, renal dysfunction, arrhythmias, thromboembolism, cardiogenic shock and repeated hospitalisation.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ATRIAL FIBRILLATION
A supraventricular tachyarrhythmia with disorganised atrial electrical activity and an irregularly irregular ventricular rhythm.
A supraventricular tachyarrhythmia with disorganised atrial electrical activity and an irregularly irregular ventricular rhythm.
Atrial Fibrillation is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Associated with age, hypertension, valvular disease, heart failure, coronary disease, hyperthyroidism, alcohol exposure, infection and postoperative states.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Atrial fibrillation results from rapid, chaotic atrial electrical activity, often sustained by atrial structural remodelling and multiple re-entry circuits. Because atrial contraction is ineffective, ventricular filling may fall and blood stasis—especially in the left atrial appendage—raises thromboembolic risk. A rapid ventricular response can further reduce cardiac output.
- Palpitations, fatigue, dyspnoea, dizziness, chest discomfort or no symptoms.
- Pulse is often irregularly irregular.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
12-lead ECG confirms the rhythm. Evaluate electrolytes, thyroid function, cardiac structure and potential precipitating causes.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Goals are stroke prevention and symptom control. Management may include anticoagulation based on thromboembolic risk, rate control, rhythm control, cardioversion or ablation in selected patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess haemodynamic stability; monitor rate and rhythm; check for stroke symptoms; administer and monitor prescribed anticoagulants or rate-control drugs; teach bleeding precautions and adherence; prepare and monitor patients undergoing cardioversion.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- A supraventricular tachyarrhythmia with disorganised atrial electrical activity and an irregularly irregular ventricular rhythm.
- Assess haemodynamic stability first.
- Monitor ventricular rate, symptoms, ECG rhythm, electrolytes and signs of stroke or heart failure.
- In patients receiving anticoagulation, monitor for bleeding and renal function where relevant.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Other irregular rhythms, frequent ectopic beats and atrial flutter with variable block may mimic AF. Reversible triggers such as sepsis, hyperthyroidism, electrolyte disturbance, acute coronary syndrome and alcohol exposure should be sought. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess haemodynamic stability first. Monitor ventricular rate, symptoms, ECG rhythm, electrolytes and signs of stroke or heart failure. In patients receiving anticoagulation, monitor for bleeding and renal function where relevant. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Ischaemic stroke/systemic embolism, heart failure and tachycardia-induced cardiomyopathy.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
INFECTIVE ENDOCARDITIS
Microbial infection of the endocardial surface of the heart, usually involving a valve and producing vegetations.
Microbial infection of the endocardial surface of the heart, usually involving a valve and producing vegetations.
Infective Endocarditis is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common organisms include Staphylococcus aureus, viridans group streptococci, enterococci and other bacteria.
- Risks include prosthetic valves, previous endocarditis, some congenital heart lesions, invasive bloodstream infection and injection drug exposure.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Endothelial injury on a cardiac valve or endocardial surface allows platelet–fibrin deposition. Transient or persistent bacteraemia can seed this surface, producing infected vegetations. These lesions may destroy valves, form abscesses or embolise to the brain, kidneys, spleen or other organs.
- Fever, malaise, new or changing murmur, embolic phenomena, petechiae and signs of heart failure; presentation may be subtle.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Multiple blood-culture sets before antibiotics when feasible, echocardiography, inflammatory markers, blood count, renal function and evaluation for embolic complications.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Prolonged targeted IV antimicrobial therapy based on culture and susceptibility; cardiac surgery may be needed for severe valve dysfunction, uncontrolled infection, abscess or recurrent embolisation.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Obtain cultures correctly before first antibiotic when ordered; monitor temperature, haemodynamics and new neurological findings; inspect IV access; monitor renal function and antimicrobial toxicity; reinforce completion of therapy and oral health.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Microbial infection of the endocardial surface of the heart, usually involving a valve and producing vegetations.
- Monitor temperature, heart sounds, haemodynamic status, neurological findings, renal function and peripheral signs of embolisation.
- New heart failure, conduction disturbance, persistent bacteraemia or embolic events may indicate complicated disease needing urgent specialist review.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Prolonged fever with murmur may also occur in rheumatic disease, autoimmune disease, occult malignancy and other systemic infections. Blood cultures and echocardiography are central to distinguishing endocarditis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor temperature, heart sounds, haemodynamic status, neurological findings, renal function and peripheral signs of embolisation. New heart failure, conduction disturbance, persistent bacteraemia or embolic events may indicate complicated disease needing urgent specialist review. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Heart failure, valve destruction, abscess, stroke, systemic emboli, kidney injury and sepsis.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
VALVULAR HEART DISEASE
Disorders causing stenosis or regurgitation of one or more cardiac valves, altering pressure and volume loads on the heart.
Disorders causing stenosis or regurgitation of one or more cardiac valves, altering pressure and volume loads on the heart.
Valvular Heart Disease is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Degenerative calcification, rheumatic heart disease, congenital abnormalities, infective endocarditis and connective-tissue disorders are important causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Valve stenosis creates pressure overload proximal to the narrowed valve, while regurgitation creates volume overload by allowing backward flow. Chronic compensation can maintain output for years, but progressive chamber enlargement, hypertrophy and rising filling pressures eventually produce dyspnoea, arrhythmia and heart failure.
- Exertional dyspnoea, fatigue, syncope, chest pain, palpitations, oedema and characteristic murmurs; some patients remain asymptomatic for years.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Echocardiography is central for valve anatomy and severity; ECG, chest imaging and exercise assessment may support evaluation.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Surveillance for mild disease, symptom-directed therapy, anticoagulation for selected conditions, and surgical or transcatheter valve repair/replacement for severe disease when indicated.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess symptoms, pulse, blood pressure, heart sounds and fluid status; monitor for heart failure and arrhythmia; provide pre-/post-procedure care for valve intervention; teach anticoagulation safety when applicable.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Disorders causing stenosis or regurgitation of one or more cardiac valves, altering pressure and volume loads on the heart.
- Assess exercise tolerance, pulse, blood pressure, heart sounds, signs of pulmonary congestion and rhythm changes.
- Sudden dyspnoea, syncope, chest pain or decompensated heart failure may indicate severe valve disease.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Symptoms may overlap with cardiomyopathy, coronary disease, pulmonary hypertension and anaemia. The murmur pattern and echocardiographic findings define the valve lesion and severity. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess exercise tolerance, pulse, blood pressure, heart sounds, signs of pulmonary congestion and rhythm changes. Sudden dyspnoea, syncope, chest pain or decompensated heart failure may indicate severe valve disease. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Heart failure, atrial fibrillation, pulmonary hypertension, thromboembolism and infective endocarditis.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
DEEP VEIN THROMBOSIS
Formation of a thrombus in a deep vein, most often in the lower limb or pelvis, with risk of embolisation to the pulmonary circulation.
Formation of a thrombus in a deep vein, most often in the lower limb or pelvis, with risk of embolisation to the pulmonary circulation.
Deep Vein Thrombosis is best understood by first relating it to normal cardiovascular physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Virchow triad: venous stasis, endothelial injury and hypercoagulability.
- Risks include surgery, immobility, cancer, pregnancy/postpartum state and previous venous thromboembolism.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
DVT arises from the interaction of venous stasis, endothelial injury and hypercoagulability. Thrombus commonly forms in the deep veins of the calf or pelvis and may propagate proximally. Detachment of part of the thrombus can produce pulmonary embolism.
- Unilateral swelling, pain, warmth and tenderness; some DVTs are clinically silent.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical probability assessment, D-dimer in suitable patients and compression ultrasonography; additional imaging may be needed in selected cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Anticoagulation is the main treatment; thrombolysis or thrombectomy is reserved for selected severe cases. Address reversible risk factors and prevention.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Measure and compare limb swelling if required; avoid vigorous massage of the affected limb; monitor for chest pain or sudden dyspnoea; administer anticoagulants safely; observe for bleeding; support mobility and compression measures when prescribed.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Formation of a thrombus in a deep vein, most often in the lower limb or pelvis, with risk of embolisation to the pulmonary circulation.
- Measure limb swelling and pain trends when indicated, assess skin temperature and colour, and monitor for new chest pain, dyspnoea, tachycardia or haemoptysis.
- Anticoagulated patients require bleeding surveillance.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Cellulitis, ruptured Baker cyst, muscle injury, chronic venous insufficiency and lymphoedema may cause similar unilateral swelling. Clinical probability tools and compression ultrasonography guide diagnosis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform focused cardiovascular assessment including pulse quality, blood pressure, perfusion, oedema, heart sounds and symptom trend. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position the patient according to haemodynamic and respiratory needs; reduce unnecessary exertion during acute symptoms. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer prescribed cardiovascular medicines safely and observe therapeutic response and adverse effects. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Maintain accurate fluid balance and daily weight when congestion or renal perfusion is a concern. Rationale: Identifies complications before they become clinically advanced.
- Provide ECG/rhythm surveillance when indicated and escalate new arrhythmia, ischaemic change or haemodynamic instability. Rationale: Reduces preventable hospital complications and supports recovery.
- Reinforce risk-factor modification, medication adherence, follow-up and symptom-based emergency advice. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Measure limb swelling and pain trends when indicated, assess skin temperature and colour, and monitor for new chest pain, dyspnoea, tachycardia or haemoptysis. Anticoagulated patients require bleeding surveillance. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take prescribed medicines consistently, keep follow-up appointments, monitor blood pressure or pulse when advised, avoid tobacco exposure, and seek urgent care for new severe chest pain, fainting, sudden weakness, or marked breathlessness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Pulmonary embolism, post-thrombotic syndrome and recurrent venous thromboembolism.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Decreased cardiac output
- Activity intolerance
- Excess fluid volume
- Acute pain
- Risk for ineffective tissue perfusion
Improvement is shown by stable haemodynamics, reduced symptoms, improved activity tolerance, adequate urine output/perfusion and absence of new complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ASTHMA
A chronic inflammatory airway disorder with variable symptoms and variable expiratory airflow limitation, usually with bronchial hyper-responsiveness.
A chronic inflammatory airway disorder with variable symptoms and variable expiratory airflow limitation, usually with bronchial hyper-responsiveness.
Asthma is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Genetic susceptibility interacts with allergens, viral infections, exercise, smoke, occupational exposures, cold air and other triggers.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Asthma combines chronic airway inflammation, bronchial hyper-responsiveness and variable expiratory airflow obstruction. Trigger exposure causes smooth-muscle constriction, mucosal oedema and mucus production. During severe attacks, air trapping increases the work of breathing and may eventually cause fatigue and respiratory failure.
- Episodic wheeze, breathlessness, chest tightness and cough, often worse at night or early morning.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Spirometry showing variable airflow limitation, peak-flow variability and response to bronchodilator; allergy assessment or inflammatory markers may support phenotyping.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Controller therapy is based on inhaled corticosteroid-containing regimens; bronchodilators relieve symptoms. Severe exacerbations require prompt assessment, repeated inhaled bronchodilator therapy, systemic corticosteroid and supportive care.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess work of breathing, respiratory rate, speech, oxygen saturation and peak flow if feasible; position upright; administer inhaled medicines using correct device technique; reassess response; teach trigger control, inhaler/spacer use and written action-plan principles.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- A chronic inflammatory airway disorder with variable symptoms and variable expiratory airflow limitation, usually with bronchial hyper-responsiveness.
- Assess respiratory rate, ability to speak, accessory-muscle use, air entry, oxygen saturation and peak expiratory flow when feasible.
- A silent chest, exhaustion, confusion, cyanosis or worsening hypoxaemia despite treatment are ominous signs.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Vocal-cord dysfunction, heart failure, COPD, anaphylaxis, foreign-body aspiration and pulmonary embolism can mimic wheeze or breathlessness. Objective demonstration of variable airflow obstruction supports asthma diagnosis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess respiratory rate, ability to speak, accessory-muscle use, air entry, oxygen saturation and peak expiratory flow when feasible. A silent chest, exhaustion, confusion, cyanosis or worsening hypoxaemia despite treatment are ominous signs. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Status asthmaticus, respiratory failure, pneumothorax and recurrent hospital attendance.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
A chronic respiratory condition characterised by persistent airflow limitation and respiratory symptoms, usually related to airway/alveolar abnormalities after exposure to harmful particles or gases.
A chronic respiratory condition characterised by persistent airflow limitation and respiratory symptoms, usually related to airway/alveolar abnormalities after exposure to harmful particles or gases.
Chronic Obstructive Pulmonary Disease is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Tobacco smoke is a major cause; biomass fuel, occupational exposure and alpha-1 antitrypsin deficiency are other contributors.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
COPD is characterised by persistent airflow limitation from small-airway disease, emphysematous destruction or both. Loss of elastic recoil and narrowed airways cause expiratory collapse, air trapping and hyperinflation. Gas-exchange abnormalities may produce chronic hypoxaemia and, in advanced disease, hypercapnia and pulmonary hypertension.
- Progressive exertional dyspnoea, chronic cough, sputum production, wheeze and recurrent exacerbations.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Post-bronchodilator spirometry confirms persistent airflow obstruction. Assess oxygenation, blood count, imaging and exacerbation causes as clinically indicated.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Smoking cessation, vaccinations, inhaled bronchodilators, selected inhaled corticosteroid combinations, pulmonary rehabilitation and oxygen for defined chronic hypoxaemia. Exacerbations may need bronchodilators, short systemic corticosteroid course and antibiotics when bacterial features are present.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess respiratory effort, sputum, oxygen saturation and mental status; use controlled oxygen as prescribed; teach pursed-lip breathing and energy conservation; reinforce inhaler technique; support nutrition and pulmonary rehabilitation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- A chronic respiratory condition characterised by persistent airflow limitation and respiratory symptoms, usually related to airway/alveolar abnormalities after exposure to harmful particles or gases.
- Observe respiratory effort, sputum volume/colour, oxygen saturation, mental state and response to bronchodilators.
- In patients at risk of chronic CO2 retention, oxygen therapy should follow controlled targets specified in local protocols.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Asthma, bronchiectasis, heart failure, interstitial lung disease and lung cancer may cause similar chronic respiratory symptoms. Spirometry after bronchodilator confirms persistent airflow obstruction. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Observe respiratory effort, sputum volume/colour, oxygen saturation, mental state and response to bronchodilators. In patients at risk of chronic CO2 retention, oxygen therapy should follow controlled targets specified in local protocols. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Respiratory failure, pulmonary hypertension, cor pulmonale, recurrent infection and weight loss/frailty.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
COMMUNITY-ACQUIRED PNEUMONIA
Acute infection of the lung parenchyma acquired outside hospital or early after admission.
Acute infection of the lung parenchyma acquired outside hospital or early after admission.
Community-Acquired Pneumonia is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common causes include Streptococcus pneumoniae, Haemophilus influenzae, respiratory viruses and atypical bacteria; the exact pathogen is often not identified.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Micro-organisms infect the distal airways and alveoli, triggering inflammatory exudate that fills airspaces and impairs ventilation. The affected regions may remain perfused despite poor ventilation, producing ventilation–perfusion mismatch and hypoxaemia.
- Fever, cough, sputum, pleuritic chest pain, dyspnoea, tachypnoea, crackles and reduced oxygen saturation; older adults may present with confusion.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical assessment, pulse oximetry and chest radiography when indicated; severity scoring and selected cultures/viral testing guide care in moderate-to-severe disease.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Appropriate antimicrobial therapy when bacterial pneumonia is suspected, plus oxygen and fluids when needed. Severe illness may require hospital or critical-care support.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor respiratory status, oxygenation, temperature and mental state; obtain cultures before antibiotics when ordered and this does not delay treatment; encourage hydration and airway clearance; mobilise as tolerated; monitor response and sepsis features.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute infection of the lung parenchyma acquired outside hospital or early after admission.
- Monitor temperature, respiratory rate, oxygen saturation, mental state, hydration, sputum and signs of sepsis.
- Failure to improve may suggest resistant infection, empyema, abscess, incorrect diagnosis or immune compromise.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Pulmonary embolism, heart failure, tuberculosis, COPD exacerbation and malignancy can mimic pneumonia. Chest imaging, clinical pattern and microbiological tests help clarify the diagnosis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor temperature, respiratory rate, oxygen saturation, mental state, hydration, sputum and signs of sepsis. Failure to improve may suggest resistant infection, empyema, abscess, incorrect diagnosis or immune compromise. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Sepsis, respiratory failure, pleural effusion/empyema and lung abscess.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PULMONARY TUBERCULOSIS
Airborne infection caused by Mycobacterium tuberculosis, commonly affecting the lungs but capable of involving almost any organ.
Airborne infection caused by Mycobacterium tuberculosis, commonly affecting the lungs but capable of involving almost any organ.
Pulmonary Tuberculosis is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Transmission occurs through inhalation of airborne droplet nuclei from a person with infectious pulmonary or laryngeal TB.
- Risk is increased by close exposure and impaired immunity.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Inhaled Mycobacterium tuberculosis reaches alveoli where macrophages ingest the organisms. Cell-mediated immunity leads to granuloma formation, which may contain infection for years. Reactivation can cause cavitation, tissue destruction and contagious pulmonary disease.
- Persistent cough, fever, night sweats, weight loss, fatigue and sometimes haemoptysis.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Sputum molecular testing, microscopy/culture and drug-susceptibility testing; chest imaging supports assessment. HIV testing is usually recommended as part of comprehensive care.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Combination anti-tuberculosis therapy is given according to national/WHO protocols and drug-susceptibility results. Drug-resistant TB requires specialist regimens.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Use airborne infection-control precautions as indicated; collect sputum correctly; support directly observed/adherence strategies where used; monitor adverse drug effects and nutrition; educate about cough hygiene, household contact evaluation and completion of treatment.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Airborne infection caused by Mycobacterium tuberculosis, commonly affecting the lungs but capable of involving almost any organ.
- Use airborne infection-control precautions when indicated, support adherence, monitor sputum conversion and watch for drug toxicity.
- New jaundice, visual symptoms, severe rash or worsening respiratory status require prompt review.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Chronic bacterial pneumonia, fungal infection, lung cancer and other causes of chronic cough and weight loss should be considered. Molecular tests, sputum microscopy/culture and imaging help confirm TB. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Use airborne infection-control precautions when indicated, support adherence, monitor sputum conversion and watch for drug toxicity. New jaundice, visual symptoms, severe rash or worsening respiratory status require prompt review. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Respiratory damage, haemoptysis, dissemination, drug resistance and ongoing transmission.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PULMONARY EMBOLISM
Obstruction of the pulmonary arterial circulation, usually by thrombus originating in the deep veins.
Obstruction of the pulmonary arterial circulation, usually by thrombus originating in the deep veins.
Pulmonary Embolism is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Risk factors mirror DVT: immobility, surgery, cancer, pregnancy/postpartum state, previous VTE and thrombophilia.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
A thrombus, usually originating from deep veins, travels to the pulmonary arteries and obstructs blood flow. This creates dead-space ventilation, increases pulmonary vascular resistance and may strain the right ventricle. Large emboli can sharply reduce left-sided filling and cause obstructive shock.
- Sudden unexplained dyspnoea, pleuritic chest pain, tachycardia, hypoxaemia, syncope or haemoptysis; massive PE may cause shock.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical probability assessment, D-dimer in appropriate low/intermediate-risk patients, CT pulmonary angiography or alternative imaging; ECG, troponin and echocardiography assist risk assessment.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Anticoagulation is standard for most cases; thrombolysis or embolectomy may be used in selected haemodynamically unstable patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Treat as urgent; monitor airway, breathing, circulation, oxygenation and cardiac rhythm; maintain IV access; administer anticoagulation safely; observe for bleeding and haemodynamic deterioration; reduce avoidable immobility after stabilisation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Obstruction of the pulmonary arterial circulation, usually by thrombus originating in the deep veins.
- Monitor oxygenation, respiratory rate, blood pressure, heart rate and signs of right-heart strain.
- Sudden hypotension, syncope, worsening hypoxaemia or chest pain suggests a high-risk event.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Acute coronary syndrome, pneumonia, pneumothorax, pericarditis and anxiety can resemble PE. Clinical probability assessment is used before selecting D-dimer or imaging strategies. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor oxygenation, respiratory rate, blood pressure, heart rate and signs of right-heart strain. Sudden hypotension, syncope, worsening hypoxaemia or chest pain suggests a high-risk event. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Obstructive shock, right-heart failure, chronic thromboembolic pulmonary hypertension and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PNEUMOTHORAX
Air within the pleural space causing partial or complete lung collapse.
Air within the pleural space causing partial or complete lung collapse.
Pneumothorax is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- May be spontaneous, traumatic or iatrogenic.
- Tension pneumothorax develops when intrapleural pressure rises and impairs venous return and ventilation.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Air entering the pleural space abolishes the negative intrapleural pressure that normally keeps the lung expanded. The affected lung partially or completely collapses. In tension pneumothorax, one-way air entry progressively raises intrathoracic pressure, compressing the opposite lung and reducing venous return.
- Sudden unilateral pleuritic pain and dyspnoea, reduced breath sounds and hyperresonance; tension physiology may produce severe respiratory distress, hypotension and mediastinal shift signs.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical diagnosis may be sufficient in life-threatening tension pneumothorax; otherwise chest imaging or ultrasound confirms the diagnosis.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Small stable cases may be observed; larger/symptomatic cases may need needle aspiration or chest drainage. Tension pneumothorax requires immediate decompression followed by definitive drainage.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Rapidly assess respiratory distress; give oxygen as prescribed; prepare equipment for decompression/chest drain; monitor drain system, bubbling, swinging and insertion site; never clamp a chest tube routinely unless specifically ordered for a defined reason.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Air within the pleural space causing partial or complete lung collapse.
- Assess breath sounds, chest expansion, oxygenation and haemodynamics.
- With a chest drain, monitor the system, insertion site and respiratory response.
- Sudden severe deterioration may indicate tension physiology.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Pulmonary embolism, severe asthma, pneumonia and musculoskeletal chest pain may present with sudden chest pain and dyspnoea. Ultrasound or radiography can confirm a non-tension pneumothorax. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess breath sounds, chest expansion, oxygenation and haemodynamics. With a chest drain, monitor the system, insertion site and respiratory response. Sudden severe deterioration may indicate tension physiology. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Tension pneumothorax, respiratory failure, recurrence and infection related to drainage.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PLEURAL EFFUSION
Abnormal accumulation of fluid in the pleural space.
Abnormal accumulation of fluid in the pleural space.
Pleural Effusion is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Transudates commonly result from heart failure or cirrhosis; exudates may occur with pneumonia, malignancy, TB, pulmonary embolism and inflammatory disease.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Pleural fluid accumulates when hydrostatic/oncotic forces are altered or when inflammation increases pleural permeability. Large effusions compress the lung and reduce ventilation. Exudative fluid suggests local pleural disease such as infection, malignancy or tuberculosis.
- Dyspnoea, pleuritic pain, reduced breath sounds, dullness to percussion and decreased chest expansion on the affected side.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Chest imaging and, when indicated, diagnostic thoracentesis with biochemical, microbiological and cytological analysis.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the cause. Therapeutic drainage may relieve large symptomatic effusions; infected pleural fluid may require antibiotics and chest-tube drainage.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor oxygenation and respiratory effort; position for comfort; prepare and assist with thoracentesis using aseptic technique; monitor after the procedure for respiratory deterioration, bleeding or pneumothorax; document fluid characteristics.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Abnormal accumulation of fluid in the pleural space.
- Monitor respiratory effort, oxygenation and pain.
- After thoracentesis, observe for pneumothorax, bleeding, re-expansion symptoms or clinical deterioration.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Atelectasis, pneumonia, elevated diaphragm and pleural thickening may resemble effusion on clinical examination. Imaging and pleural-fluid analysis help determine the cause. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor respiratory effort, oxygenation and pain. After thoracentesis, observe for pneumothorax, bleeding, re-expansion symptoms or clinical deterioration. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Empyema, trapped lung, pneumothorax after procedure and respiratory compromise.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE RESPIRATORY DISTRESS SYNDROME
Acute diffuse inflammatory lung injury causing increased pulmonary vascular permeability, bilateral opacities and severe hypoxaemia not fully explained by cardiac failure.
Acute diffuse inflammatory lung injury causing increased pulmonary vascular permeability, bilateral opacities and severe hypoxaemia not fully explained by cardiac failure.
Acute Respiratory Distress Syndrome is best understood by first relating it to normal respiratory physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common triggers include sepsis, severe pneumonia, aspiration, major trauma and pancreatitis.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
ARDS follows diffuse inflammatory injury to the alveolar–capillary membrane. Increased permeability causes protein-rich pulmonary oedema, loss of surfactant, reduced compliance and severe shunt physiology. The lungs become stiff and difficult to ventilate, while systemic inflammation may contribute to multi-organ failure.
- Rapidly progressive dyspnoea, tachypnoea, hypoxaemia and diffuse crackles, often in a critically ill patient.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Arterial blood gases, chest imaging and assessment of oxygenation severity; echocardiography or other tests may help exclude primary cardiogenic pulmonary oedema.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the underlying cause, use lung-protective mechanical ventilation when intubated, conservative fluid strategies when appropriate, prone positioning in selected severe cases and comprehensive critical care.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Continuous respiratory and haemodynamic monitoring; ventilator and airway care; pressure-area, eye and line protection during proning; strict fluid balance; prevent ventilator-associated complications; provide sedation/delirium assessment and family communication.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute diffuse inflammatory lung injury causing increased pulmonary vascular permeability, bilateral opacities and severe hypoxaemia not fully explained by cardiac failure.
- Continuous oxygenation, ventilator parameters and haemodynamics are required in severe disease.
- Nurses monitor prone-position safety, sedation, pressure areas, fluid balance and complications such as barotrauma or ventilator-associated infection.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Cardiogenic pulmonary oedema is the major alternative diagnosis. Clinical context, echocardiography and haemodynamic assessment help distinguish them. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess respiratory rate, pattern, work of breathing, breath sounds, oxygen saturation and mental state at appropriate intervals. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Position upright when tolerated to optimise diaphragmatic movement and ventilation. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer oxygen and inhaled/systemic therapies exactly as prescribed and reassess objective response. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Promote airway clearance with hydration, coughing, physiotherapy or suction when clinically indicated. Rationale: Identifies complications before they become clinically advanced.
- Cluster care and conserve energy in patients with severe dyspnoea or limited reserve. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate falling saturation, silent chest, exhaustion, cyanosis, new confusion or haemodynamic instability immediately. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Continuous oxygenation, ventilator parameters and haemodynamics are required in severe disease. Nurses monitor prone-position safety, sedation, pressure areas, fluid balance and complications such as barotrauma or ventilator-associated infection. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Use inhalers and other medicines exactly as taught, avoid tobacco smoke and recognised triggers, keep vaccinations current where recommended, practise infection-prevention measures, and seek urgent help for severe breathlessness, cyanosis, confusion, or rapidly falling oxygen saturation.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Multi-organ failure, ventilator-associated infection, barotrauma, thromboembolism, ICU-acquired weakness and long-term functional impairment.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired gas exchange
- Ineffective airway clearance
- Ineffective breathing pattern
- Activity intolerance
- Anxiety related to breathlessness
Desired outcomes include easier breathing, improved oxygenation, reduced work of breathing, effective secretion clearance and stable mental status. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
GASTRO-OESOPHAGEAL REFLUX DISEASE
Reflux of gastric contents into the oesophagus causing troublesome symptoms or complications.
Reflux of gastric contents into the oesophagus causing troublesome symptoms or complications.
Gastro-oesophageal Reflux Disease is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Transient lower oesophageal sphincter relaxation, hiatal hernia, obesity, pregnancy and some foods/medicines may contribute.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
GERD develops when the anti-reflux barrier at the lower oesophageal sphincter is ineffective, allowing acidic gastric contents to contact the oesophageal mucosa. Repeated exposure causes inflammation and, in some patients, metaplastic change.
- Heartburn, acid regurgitation, sour taste and sometimes chronic cough or laryngeal symptoms.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Often diagnosed clinically; endoscopy is used for alarm features, complications or refractory symptoms. pH monitoring may be used when diagnosis remains uncertain.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Weight and meal-timing measures, acid suppression with proton-pump inhibitors or H2 blockers, and selected anti-reflux procedures for refractory or complicated disease.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess symptom pattern and alarm features such as dysphagia, bleeding or weight loss; reinforce smaller meals, avoiding late meals and individually identified triggers; teach correct timing of prescribed acid suppression.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Reflux of gastric contents into the oesophagus causing troublesome symptoms or complications.
- Track symptom frequency, relation to meals and response to therapy.
- Dysphagia, odynophagia, bleeding, anaemia or unexplained weight loss are red flags.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Peptic ulcer disease, angina, biliary disease and oesophageal motility disorders may cause similar upper abdominal or chest symptoms. Alarm features require endoscopic evaluation. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Track symptom frequency, relation to meals and response to therapy. Dysphagia, odynophagia, bleeding, anaemia or unexplained weight loss are red flags. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Oesophagitis, stricture, Barrett oesophagus and aspiration-related symptoms.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PEPTIC ULCER DISEASE
Ulceration of the stomach or duodenal mucosa, commonly associated with Helicobacter pylori infection or NSAID exposure.
Ulceration of the stomach or duodenal mucosa, commonly associated with Helicobacter pylori infection or NSAID exposure.
Peptic Ulcer Disease is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- H. pylori, NSAIDs and less commonly hypersecretory states or severe physiological stress.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Ulceration occurs when gastric or duodenal mucosal defences are overwhelmed by acid–pepsin injury. Helicobacter pylori disrupts mucosal protection and causes chronic inflammation, while NSAIDs reduce protective prostaglandins.
- Epigastric burning or gnawing pain, dyspepsia, nausea; bleeding may cause melaena, haematemesis or anaemia.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
H. pylori testing, upper endoscopy for alarm features or complications, full blood count and assessment for bleeding.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Acid suppression, H. pylori eradication when present, stopping or minimising ulcerogenic drugs when possible, and endoscopic/surgical treatment for complications.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor pain and gastrointestinal bleeding; check haemodynamic status if bleeding is suspected; administer prescribed PPI and eradication therapy; reinforce medication completion and avoidance of unnecessary NSAIDs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Ulceration of the stomach or duodenal mucosa, commonly associated with Helicobacter pylori infection or NSAID exposure.
- Monitor pain, haemodynamic status and signs of GI bleeding.
- Sudden severe abdominal pain with rigidity may indicate perforation and requires emergency assessment.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
GERD, gastritis, pancreatitis, biliary disease and gastric malignancy may present similarly. Upper GI bleeding or perforation changes the urgency of care. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor pain, haemodynamic status and signs of GI bleeding. Sudden severe abdominal pain with rigidity may indicate perforation and requires emergency assessment. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Upper GI bleeding, perforation, penetration and gastric outlet obstruction.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE GASTROENTERITIS
Acute inflammation of the stomach and intestines causing diarrhoea, vomiting or both, most often infectious.
Acute inflammation of the stomach and intestines causing diarrhoea, vomiting or both, most often infectious.
Acute Gastroenteritis is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Viruses are common; bacteria and parasites are important depending on exposure, food/water safety, travel and immune status.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Enteric pathogens disrupt intestinal absorption and may stimulate secretion or directly damage mucosa. The major physiological threat is fluid and electrolyte loss, particularly in infants, older adults and patients with comorbidity.
- Watery diarrhoea, vomiting, abdominal cramps, fever and dehydration.
- Blood in stool, severe pain or persistent fever suggests invasive disease or another diagnosis.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Usually clinical. Stool studies are reserved for severe, persistent, bloody, outbreak-related or high-risk cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Oral rehydration is the foundation; IV fluids for significant dehydration or inability to drink. Antimicrobial therapy is selective and pathogen/risk dependent.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess hydration, urine output, pulse and mental state; record stool/vomit losses; use enteric/contact precautions when indicated; support oral rehydration and safe feeding; monitor vulnerable patients closely.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute inflammation of the stomach and intestines causing diarrhoea, vomiting or both, most often infectious.
- Assess hydration, mucous membranes, pulse, blood pressure, urine output, mental state and stool frequency.
- Bloody diarrhoea, persistent high fever, severe pain or shock are warning signs.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Inflammatory bowel disease, appendicitis, bowel obstruction, medication-related diarrhoea and endocrine causes should be considered when symptoms are atypical or prolonged. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess hydration, mucous membranes, pulse, blood pressure, urine output, mental state and stool frequency. Bloody diarrhoea, persistent high fever, severe pain or shock are warning signs. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Dehydration, electrolyte imbalance, acute kidney injury, haemolytic uraemic syndrome with certain pathogens and sepsis.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE APPENDICITIS
Inflammation of the appendix, usually following luminal obstruction, with risk of perforation if untreated.
Inflammation of the appendix, usually following luminal obstruction, with risk of perforation if untreated.
Acute Appendicitis is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Obstruction from lymphoid hyperplasia, faecalith and less commonly other causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Luminal obstruction raises intraluminal pressure, impairs venous drainage and promotes bacterial overgrowth. Progressive inflammation can cause ischaemia, gangrene and perforation with local or generalised peritonitis.
- Pain often starts centrally then localises to the right lower quadrant, with anorexia, nausea, low-grade fever and local tenderness.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical assessment, full blood count/CRP, urinalysis, pregnancy test when relevant and ultrasound or CT depending on patient and setting.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Appendectomy is standard for many patients; antibiotics are given perioperatively and non-operative antibiotic treatment may be considered in selected uncomplicated cases under surgical guidance.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Keep patient fasting when surgery is possible; monitor pain, fever and peritoneal signs; maintain IV fluids as prescribed; prepare for surgery; provide postoperative wound, mobility and respiratory care.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inflammation of the appendix, usually following luminal obstruction, with risk of perforation if untreated.
- Track pain location/intensity, temperature, pulse and peritoneal signs.
- Increasing diffuse pain, rigidity, fever or haemodynamic deterioration may indicate perforation or sepsis.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Gastroenteritis, mesenteric adenitis, renal colic, urinary infection, ectopic pregnancy, ovarian pathology and inflammatory bowel disease may mimic appendicitis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Track pain location/intensity, temperature, pulse and peritoneal signs. Increasing diffuse pain, rigidity, fever or haemodynamic deterioration may indicate perforation or sepsis. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Perforation, peritonitis, abscess and sepsis.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
INTESTINAL OBSTRUCTION
Partial or complete blockage preventing normal movement of intestinal contents.
Partial or complete blockage preventing normal movement of intestinal contents.
Intestinal Obstruction is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Adhesions, hernia, tumour, volvulus, intussusception and inflammatory strictures are common mechanical causes; ileus causes functional obstruction.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Mechanical blockage prevents forward movement of intestinal contents. Proximal distension causes fluid sequestration and vomiting, while strangulation compromises blood supply and can lead to necrosis and perforation. Functional ileus produces similar stasis without a mechanical blockage.
- Colicky abdominal pain, distension, vomiting, constipation/obstipation and altered bowel sounds.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical examination, electrolytes, blood count/lactate where indicated and abdominal CT or radiography.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Bowel rest, IV fluids, electrolyte correction, nasogastric decompression in selected patients and surgery for strangulation, perforation, complete obstruction or failed conservative management.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor pain, distension, vomiting, bowel function, fluid balance and electrolytes; maintain NPO status; care for NG tube if present; watch for peritonitis, fever, tachycardia and increasing pain suggesting ischaemia.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Partial or complete blockage preventing normal movement of intestinal contents.
- Monitor abdominal distension, pain pattern, vomiting, bowel sounds, fluid balance and electrolytes.
- Continuous severe pain, fever, tachycardia or peritoneal signs suggest ischaemia or perforation.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Severe constipation, gastroenteritis, pseudo-obstruction and acute abdominal inflammatory disorders may mimic obstruction. CT helps define level, cause and complications. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor abdominal distension, pain pattern, vomiting, bowel sounds, fluid balance and electrolytes. Continuous severe pain, fever, tachycardia or peritoneal signs suggest ischaemia or perforation. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Bowel ischaemia, necrosis, perforation, peritonitis, sepsis and fluid/electrolyte depletion.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
VIRAL HEPATITIS
Inflammation of the liver caused by hepatotropic viruses. Hepatitis A and E are mainly enterically transmitted; B, C and D are mainly blood/body-fluid related.
Inflammation of the liver caused by hepatotropic viruses. Hepatitis A and E are mainly enterically transmitted; B, C and D are mainly blood/body-fluid related.
Viral Hepatitis is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- HAV, HBV, HCV, HDV and HEV differ in transmission, chronicity and prevention.
- HBV and HCV are major causes of chronic liver disease.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Hepatotropic viruses infect hepatocytes and provoke immune-mediated injury. Acute inflammation raises aminotransferases and may impair bilirubin processing. Chronic HBV and HCV can drive progressive fibrosis, cirrhosis and hepatocellular carcinoma.
- May be asymptomatic or cause fatigue, anorexia, nausea, right upper quadrant discomfort, jaundice, dark urine and raised transaminases.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Liver biochemical tests and virus-specific antigen/antibody or nucleic-acid tests according to suspected type.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Supportive care for many acute infections; chronic HBV and HCV have specific antiviral strategies. Vaccination prevents hepatitis A and B in appropriate populations.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor jaundice, bleeding tendency, mental state and liver tests; support nutrition and rest; reinforce infection-prevention measures, vaccine advice and avoidance of unnecessary hepatotoxic substances; promote follow-up for chronic infection.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inflammation of the liver caused by hepatotropic viruses.
- Hepatitis A and E are mainly enterically transmitted; B, C and D are mainly blood/body-fluid related.
- Observe mental state, INR/coagulation, bilirubin, aminotransferases and hydration.
- Encephalopathy, rising INR, hypoglycaemia or rapid clinical decline can indicate acute liver failure.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Drug-induced liver injury, alcoholic hepatitis, biliary obstruction, autoimmune hepatitis and metabolic liver disease may produce similar jaundice or abnormal liver tests. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Observe mental state, INR/coagulation, bilirubin, aminotransferases and hydration. Encephalopathy, rising INR, hypoglycaemia or rapid clinical decline can indicate acute liver failure. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Fulminant hepatitis, chronic hepatitis, cirrhosis, portal hypertension and hepatocellular carcinoma, especially with chronic HBV/HCV.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
LIVER CIRRHOSIS
Advanced chronic liver fibrosis with regenerative nodules, portal hypertension and impaired synthetic/metabolic function.
Advanced chronic liver fibrosis with regenerative nodules, portal hypertension and impaired synthetic/metabolic function.
Liver Cirrhosis is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Chronic viral hepatitis, alcohol-related liver disease, metabolic dysfunction-associated steatotic liver disease, autoimmune and cholestatic disease are major causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Repeated hepatic injury leads to fibrosis and regenerative nodules that distort normal architecture. Portal resistance increases, producing portal hypertension, while loss of functioning hepatocytes impairs protein synthesis, detoxification and metabolic regulation.
- Fatigue, jaundice, ascites, oedema, spider naevi, splenomegaly, varices, bruising and hepatic encephalopathy.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Liver tests, INR, albumin, blood count, ultrasound/elastography and evaluation of aetiology; endoscopy and surveillance imaging are used for complications.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the underlying cause; manage ascites, varices and encephalopathy; nutritional support; vaccination; transplant assessment for decompensated disease.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Daily weight and abdominal girth when ascites is significant; strict fluid balance; monitor mental status, bleeding and infection; support low-sodium diet when prescribed; administer lactulose/diuretics and monitor response; avoid unnecessary invasive procedures when coagulopathy is severe.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Advanced chronic liver fibrosis with regenerative nodules, portal hypertension and impaired synthetic/metabolic function.
- Monitor weight, abdominal girth, fluid balance, mental state, bleeding, infection and renal function.
- New confusion, GI bleeding, fever with ascites or rapidly rising creatinine are high-risk complications.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Heart failure, nephrotic syndrome and malignancy may also cause ascites or oedema. Imaging, laboratory findings and aetiological testing help establish cirrhosis and its cause. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor weight, abdominal girth, fluid balance, mental state, bleeding, infection and renal function. New confusion, GI bleeding, fever with ascites or rapidly rising creatinine are high-risk complications. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Variceal bleeding, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome and hepatocellular carcinoma.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE PANCREATITIS
Acute inflammation of the pancreas, ranging from mild self-limiting disease to severe systemic inflammation and organ failure.
Acute inflammation of the pancreas, ranging from mild self-limiting disease to severe systemic inflammation and organ failure.
Acute Pancreatitis is best understood by first relating it to normal gastrointestinal & hepatobiliary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Gallstones and alcohol are common causes; hypertriglyceridaemia, medicines, trauma and procedures can also cause pancreatitis.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Premature activation of pancreatic digestive enzymes causes autodigestion and inflammation. Local injury can extend into peripancreatic tissues, while cytokine release may cause systemic inflammatory response, capillary leak and organ failure.
- Severe epigastric pain often radiating to the back, nausea, vomiting and abdominal tenderness.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Typical pain plus raised lipase/amylase and/or characteristic imaging. Assess electrolytes, renal function, haematocrit and severity markers.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Early supportive care with appropriate IV fluids, analgesia, early enteral nutrition as tolerated, treatment of the cause and management of complications. Antibiotics are not routine for uncomplicated sterile pancreatitis.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent pain, haemodynamic and respiratory assessment; strict fluid balance; monitor glucose, calcium and renal function; support early enteral feeding plan; observe for worsening organ dysfunction or infection.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute inflammation of the pancreas, ranging from mild self-limiting disease to severe systemic inflammation and organ failure.
- Monitor pain, fluid status, oxygenation, renal function, haematocrit, calcium and glucose.
- Persistent organ dysfunction, rising inflammatory markers or new fever may indicate severe disease or infected necrosis.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Perforated ulcer, biliary colic/cholecystitis, myocardial infarction and mesenteric ischaemia can mimic upper abdominal pain radiating to the back. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess abdominal pain, distension, bowel sounds, nausea/vomiting, stool pattern and signs of peritonitis or bleeding. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Maintain prescribed NPO status, enteral intake or therapeutic diet and explain the reason to the patient. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Record fluid losses carefully and monitor hydration, electrolytes and urine output. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Administer prescribed antiemetics, acid suppression, analgesia or antimicrobials and evaluate effect. Rationale: Identifies complications before they become clinically advanced.
- Observe vomit and stool for blood when relevant and escalate haemodynamic deterioration. Rationale: Reduces preventable hospital complications and supports recovery.
- Support nutrition, infection prevention and discharge teaching tailored to the underlying diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor pain, fluid status, oxygenation, renal function, haematocrit, calcium and glucose. Persistent organ dysfunction, rising inflammatory markers or new fever may indicate severe disease or infected necrosis. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the prescribed diet and medication plan, maintain hydration unless restricted, avoid unnecessary NSAID use when relevant, observe stool or vomit for blood, and seek urgent care for severe persistent abdominal pain, haematemesis, melaena, rigid abdomen, or signs of dehydration.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Shock, ARDS, acute kidney injury, pancreatic necrosis, pseudocyst and infected collections.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Risk for deficient fluid volume
- Imbalanced nutrition
- Risk for bleeding
- Risk for infection
Improvement includes controlled pain, stable fluid/electrolyte status, adequate nutrition, resolution of bleeding or infection signs and return of appropriate bowel function. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE KIDNEY INJURY
Abrupt decline in kidney function causing accumulation of nitrogenous waste and disturbances in fluid, electrolyte and acid-base balance.
Abrupt decline in kidney function causing accumulation of nitrogenous waste and disturbances in fluid, electrolyte and acid-base balance.
Acute Kidney Injury is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Prerenal hypoperfusion, intrinsic renal injury and postrenal obstruction are major categories.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
AKI reflects an abrupt fall in glomerular filtration from renal hypoperfusion, intrinsic renal damage or urinary obstruction. Reduced filtration leads to retention of potassium, acid, water and nitrogenous waste. Some forms are reversible when the cause is corrected early.
- Reduced urine output may occur but is not universal; oedema, nausea, confusion, dyspnoea and arrhythmia can result from complications.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Serial creatinine, urine output, electrolytes, urinalysis, medication review and ultrasound when obstruction is possible.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the cause, optimise perfusion, stop/adjust nephrotoxic medicines when appropriate, correct dangerous electrolyte/acid-base problems and use renal replacement therapy for selected complications.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Strict intake/output and daily weight; monitor blood pressure, oedema, lung sounds, potassium and ECG when indicated; review medication doses with the team; protect vascular access; support prescribed fluid and dietary plan.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Abrupt decline in kidney function causing accumulation of nitrogenous waste and disturbances in fluid, electrolyte and acid-base balance.
- Strict intake/output, daily weight, creatinine, potassium, bicarbonate, blood pressure and signs of pulmonary oedema are essential.
- Hyperkalaemia, severe acidosis, uraemic complications or refractory overload may require urgent renal replacement therapy.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Chronic kidney disease with stable elevated creatinine must be distinguished from acute change. Urinalysis, history, ultrasound and trends in creatinine/urine output help define the category. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Strict intake/output, daily weight, creatinine, potassium, bicarbonate, blood pressure and signs of pulmonary oedema are essential. Hyperkalaemia, severe acidosis, uraemic complications or refractory overload may require urgent renal replacement therapy. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hyperkalaemia, pulmonary oedema, metabolic acidosis, uraemic complications and progression to CKD.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
CHRONIC KIDNEY DISEASE
Abnormal kidney structure or function present for at least three months with implications for health, commonly classified by eGFR and albuminuria.
Abnormal kidney structure or function present for at least three months with implications for health, commonly classified by eGFR and albuminuria.
Chronic Kidney Disease is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Diabetes, hypertension, glomerular disease, hereditary disease and chronic obstruction are common causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
CKD involves persistent nephron loss and reduced filtration. Surviving nephrons hyperfilter, which initially preserves function but can accelerate glomerular damage. Progressive disease also disrupts erythropoietin production, vitamin D activation, phosphate handling and acid–base control.
- Often asymptomatic early; later features include fatigue, pruritus, oedema, anaemia, hypertension, nausea and uraemic symptoms.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
eGFR trend, urine albumin-to-creatinine ratio, urinalysis, electrolytes, calcium/phosphate, blood count and renal imaging when indicated.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Control the cause and cardiovascular risk, use kidney-protective therapies when appropriate, manage anaemia/mineral-bone disorder, and plan dialysis or transplantation for advanced kidney failure.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor fluid status, BP, weight and labs; teach medication and dietary plans; protect potential dialysis access arm; monitor for uraemia and hyperkalaemia; provide dialysis education and psychosocial support.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Abnormal kidney structure or function present for at least three months with implications for health, commonly classified by eGFR and albuminuria.
- Trend eGFR, albuminuria, potassium, bicarbonate, haemoglobin, calcium/phosphate, fluid status and blood pressure.
- Preparation for kidney replacement therapy should begin before advanced symptoms develop.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Acute kidney injury, urinary obstruction and isolated proteinuria without chronic structural disease should be distinguished using duration, imaging and prior laboratory values. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Trend eGFR, albuminuria, potassium, bicarbonate, haemoglobin, calcium/phosphate, fluid status and blood pressure. Preparation for kidney replacement therapy should begin before advanced symptoms develop. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Kidney failure, cardiovascular disease, anaemia, mineral-bone disorder, hyperkalaemia, acidosis and fluid overload.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
LOWER URINARY TRACT INFECTION
Infection involving the bladder/urethra, most often bacterial cystitis.
Infection involving the bladder/urethra, most often bacterial cystitis.
Lower Urinary Tract Infection is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Escherichia coli is the most common cause; other Enterobacterales and urinary pathogens occur.
- Risks include sexual activity, pregnancy, urinary obstruction and catheter use.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Bacteria ascend the urethra and colonise the bladder mucosa, producing local inflammation. Most uncomplicated cases remain confined to the lower tract, but untreated or complicated infection may ascend to the kidneys.
- Dysuria, frequency, urgency and suprapubic discomfort without systemic signs of upper tract infection.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urinalysis; urine culture is especially useful in complicated, recurrent, pregnant or treatment-failure cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Appropriate short-course antimicrobial therapy based on local guidance and patient factors; hydration and analgesia as needed.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Collect a clean-catch specimen before antibiotics when ordered; monitor fever/flank pain suggesting pyelonephritis; encourage adequate fluid intake unless restricted; reinforce completion of treatment and catheter-care principles.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Infection involving the bladder/urethra, most often bacterial cystitis.
- Monitor urinary symptoms, fever and hydration.
- Persistent symptoms after therapy, recurrent infection or systemic signs may require culture review and evaluation for obstruction or resistant organisms.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Vaginitis, urethritis/STIs, interstitial cystitis and nephrolithiasis can cause dysuria. Fever and flank pain suggest upper tract involvement rather than isolated cystitis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor urinary symptoms, fever and hydration. Persistent symptoms after therapy, recurrent infection or systemic signs may require culture review and evaluation for obstruction or resistant organisms. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Ascending pyelonephritis, recurrent infection and sepsis in high-risk patients.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE PYELONEPHRITIS
Bacterial infection of the renal pelvis and kidney parenchyma.
Bacterial infection of the renal pelvis and kidney parenchyma.
Acute Pyelonephritis is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Usually ascending infection from the lower urinary tract; E. coli is common.
- Obstruction and pregnancy increase risk.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Ascending bacteria infect the renal pelvis and parenchyma, producing tubulointerstitial inflammation. Obstruction greatly increases the risk of sepsis and renal damage.
- Fever, chills, flank pain, costovertebral-angle tenderness, nausea/vomiting and urinary symptoms.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urinalysis and urine culture; blood cultures and imaging for severe, complicated or non-responding cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Prompt antimicrobial therapy and fluids; hospital care and IV antibiotics for severe illness; urgent relief of an infected obstruction.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor temperature, pain, hydration, urine output and sepsis indicators; obtain cultures promptly; administer prescribed antibiotics; encourage fluids if appropriate; escalate persistent fever or obstruction signs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Bacterial infection of the renal pelvis and kidney parenchyma.
- Monitor temperature, pulse, blood pressure, pain, urine output and sepsis markers.
- Failure to improve should prompt evaluation for obstruction, abscess or resistant infection.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Renal colic, lower UTI, appendicitis and other causes of flank or abdominal pain may resemble pyelonephritis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor temperature, pulse, blood pressure, pain, urine output and sepsis markers. Failure to improve should prompt evaluation for obstruction, abscess or resistant infection. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Sepsis, renal/perinephric abscess, papillary necrosis and renal impairment.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
NEPHROTIC SYNDROME
Glomerular disorder characterised by heavy proteinuria, hypoalbuminaemia, oedema and hyperlipidaemia.
Glomerular disorder characterised by heavy proteinuria, hypoalbuminaemia, oedema and hyperlipidaemia.
Nephrotic Syndrome is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- May be primary glomerular disease or secondary to diabetes, lupus, infections, medicines and malignancy.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Damage to the glomerular filtration barrier allows excessive protein loss in urine. Hypoalbuminaemia lowers plasma oncotic pressure and contributes to oedema. Hepatic lipid synthesis increases, and urinary loss of anticoagulant proteins contributes to thrombosis risk.
- Generalised or dependent oedema, frothy urine, weight gain and increased risk of infection and thrombosis.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urine protein quantification, serum albumin, renal function, lipids and tests for secondary causes; kidney biopsy is used in selected patients.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the cause, control oedema and blood pressure, reduce proteinuria, manage lipids and assess thrombosis/infection risk. Immunosuppression is used for selected histological diagnoses.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Daily weights, oedema/skin assessment and strict fluid balance; monitor BP and renal function; protect oedematous skin; support prescribed sodium/fluid limits; watch for infection and thromboembolic symptoms.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Glomerular disorder characterised by heavy proteinuria, hypoalbuminaemia, oedema and hyperlipidaemia.
- Daily weight, oedema, skin integrity, blood pressure, urine protein, renal function and signs of thrombosis or infection should be monitored.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
- Venous thrombosis, infection, acute kidney injury, malnutrition and progressive CKD.
Heart failure, cirrhosis and other causes of generalised oedema may mimic nephrotic syndrome. Quantifying proteinuria and assessing serum albumin and renal function are central. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Daily weight, oedema, skin integrity, blood pressure, urine protein, renal function and signs of thrombosis or infection should be monitored. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Venous thrombosis, infection, acute kidney injury, malnutrition and progressive CKD.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
GLOMERULONEPHRITIS
Inflammation of the renal glomeruli causing haematuria, proteinuria and varying degrees of kidney dysfunction.
Inflammation of the renal glomeruli causing haematuria, proteinuria and varying degrees of kidney dysfunction.
Glomerulonephritis is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Post-infectious disease, IgA nephropathy, lupus, vasculitis and anti-GBM disease are important causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Immune-mediated injury to glomerular capillaries causes haematuria, reduced filtration and variable protein leakage. In severe forms, rapidly progressive crescent formation can produce abrupt kidney failure.
- Dark or cola-coloured urine, oedema, hypertension, reduced urine output and sometimes systemic inflammatory features.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urinalysis with microscopy, urine protein, renal function, complement and autoimmune/infectious tests; biopsy may define the diagnosis.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Cause-specific therapy may include supportive BP/fluid control, antibiotics for an active infection when indicated and immunosuppression for selected immune-mediated disease.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor BP, weight, urine output and fluid status; observe for pulmonary oedema and hyperkalaemia; administer prescribed medicines; explain fluid/sodium restrictions when ordered; prepare patients for renal biopsy if required.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inflammation of the renal glomeruli causing haematuria, proteinuria and varying degrees of kidney dysfunction.
- Monitor blood pressure, urine output, weight, potassium and respiratory status.
- Worsening oliguria, pulmonary oedema or severe hypertension indicates significant renal dysfunction.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
UTI, renal stones and anticoagulant-related haematuria may cause blood in urine without glomerular inflammation. Urine microscopy, protein pattern and serology help distinguish glomerular disease. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor blood pressure, urine output, weight, potassium and respiratory status. Worsening oliguria, pulmonary oedema or severe hypertension indicates significant renal dysfunction. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
AKI, nephritic syndrome, hypertension, CKD and rapidly progressive kidney failure.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
RENAL CALCULI
Crystalline stones within the urinary tract that may cause obstruction, renal colic and haematuria.
Crystalline stones within the urinary tract that may cause obstruction, renal colic and haematuria.
Renal Calculi is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Calcium stones are most common; uric acid, struvite and cystine stones have distinct risk factors.
- Low urine volume is a major modifiable risk.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Urinary supersaturation leads to crystal nucleation, growth and stone formation. Obstruction causes ureteric smooth-muscle spasm and intense colicky pain. Infection behind an obstructing stone can rapidly progress to sepsis.
- Severe colicky flank pain radiating toward the groin, haematuria, nausea and restlessness.
- Fever with obstruction is an emergency.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urinalysis, renal function and non-contrast CT or ultrasound depending on patient factors; stone analysis helps prevention.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Analgesia, antiemetics, hydration according to status, selected medical expulsive therapy, and urological intervention for large, persistent or complicated stones.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain, vital signs and urine output; strain urine when requested; monitor for fever/anuria; encourage long-term fluid intake and diet tailored to stone type after evaluation; prepare for lithotripsy or endoscopic treatment when planned.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Crystalline stones within the urinary tract that may cause obstruction, renal colic and haematuria.
- Assess pain, urine output, haematuria and fever.
- Anuria, solitary-kidney obstruction or fever with obstruction are urgent urological problems.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Pyelonephritis, appendicitis, ectopic pregnancy and musculoskeletal pain may mimic renal colic. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess pain, urine output, haematuria and fever. Anuria, solitary-kidney obstruction or fever with obstruction are urgent urological problems. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hydronephrosis, infection, sepsis, acute kidney injury and recurrent stones.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ACUTE URINARY RETENTION
Sudden inability to empty the bladder despite a full bladder, producing painful distension and risk of kidney injury.
Sudden inability to empty the bladder despite a full bladder, producing painful distension and risk of kidney injury.
Acute Urinary Retention is best understood by first relating it to normal renal & urinary physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Benign prostatic enlargement, medicines with anticholinergic effects, urethral obstruction, neurological disease and postoperative factors.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Outflow obstruction or impaired detrusor contraction prevents complete bladder emptying. Rising intravesical pressure causes painful distension and, if severe or prolonged, can impair upper urinary tract drainage and kidney function.
- Suprapubic pain, palpable/distended bladder, inability to void or frequent small amounts with overflow.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Bladder scan, urinalysis, renal function and evaluation of the cause.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Prompt bladder decompression with catheterisation when appropriate, followed by treatment of the underlying cause and urological review.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain and bladder distension; use bladder scanner if available; insert catheter with aseptic technique when ordered; document residual volume and urine characteristics; monitor post-obstructive diuresis in high-volume retention.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Sudden inability to empty the bladder despite a full bladder, producing painful distension and risk of kidney injury.
- After catheterisation, document residual volume and urine characteristics and monitor for post-obstructive diuresis in large-volume retention.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
- UTI, hydronephrosis, postrenal AKI and bladder dysfunction.
Severe constipation, neurogenic bladder and overflow incontinence may present similarly. Bladder scanning helps confirm retention. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Measure urine output accurately and relate it to fluid intake, blood pressure and renal-function trends. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Monitor weight, oedema, lung sounds and blood pressure for evidence of fluid overload or depletion. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Review potassium, sodium, bicarbonate, urea and creatinine trends and report dangerous abnormalities. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use catheter care, specimen collection and aseptic technique appropriately to reduce infection risk. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed renal, antimicrobial, analgesic or fluid therapy and monitor response. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach fluid, diet, medication and follow-up plans according to the individual renal diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
After catheterisation, document residual volume and urine characteristics and monitor for post-obstructive diuresis in large-volume retention. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow the individual fluid, diet and medication plan; monitor weight, blood pressure and urine output when advised; avoid unapproved nephrotoxic medicines; and seek urgent care for anuria, severe swelling, breathing difficulty, fever with flank pain, or marked weakness/palpitations.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
UTI, hydronephrosis, postrenal AKI and bladder dysfunction.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Impaired urinary elimination
- Excess fluid volume
- Risk for electrolyte imbalance
- Acute pain
- Risk for infection
Desired outcomes include adequate urine output when expected, stable electrolytes, improved pain, controlled infection and absence of pulmonary oedema or worsening renal injury. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
TYPE 1 DIABETES MELLITUS
Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency and lifelong dependence on exogenous insulin.
Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency and lifelong dependence on exogenous insulin.
Type 1 Diabetes Mellitus is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Autoimmune susceptibility with genetic and environmental influences; it can develop at any age.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Autoimmune destruction of pancreatic beta cells causes absolute insulin deficiency. Without insulin, glucose uptake falls while hepatic glucose output, lipolysis and ketogenesis rise. Exogenous insulin is therefore essential for survival.
- Polyuria, polydipsia, weight loss, fatigue, blurred vision and possible presentation with diabetic ketoacidosis.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Plasma glucose/HbA1c diagnostic criteria in the appropriate clinical context; ketones in acute illness; autoantibodies/C-peptide may help classify uncertain cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Basal-bolus or pump insulin therapy, glucose monitoring, carbohydrate-informed meal planning, education and prevention of microvascular/macrovascular complications.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Teach insulin administration and site rotation, glucose/ketone monitoring, recognition/treatment of hypoglycaemia, sick-day rules, foot care and carrying rapid carbohydrate; support psychosocial adaptation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency and lifelong dependence on exogenous insulin.
- Monitor glucose patterns, hypoglycaemia, ketones during illness, injection or pump sites and long-term renal, eye and neurological complications.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
- DKA, severe hypoglycaemia, retinopathy, nephropathy, neuropathy and cardiovascular disease.
Type 2 diabetes, monogenic diabetes and secondary diabetes can occasionally be confused with type 1 disease, especially at atypical ages. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor glucose patterns, hypoglycaemia, ketones during illness, injection or pump sites and long-term renal, eye and neurological complications. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
DKA, severe hypoglycaemia, retinopathy, nephropathy, neuropathy and cardiovascular disease.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
TYPE 2 DIABETES MELLITUS
Chronic metabolic disease characterised by insulin resistance and progressive beta-cell dysfunction causing hyperglycaemia.
Chronic metabolic disease characterised by insulin resistance and progressive beta-cell dysfunction causing hyperglycaemia.
Type 2 Diabetes Mellitus is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Genetic predisposition interacts with age, excess adiposity, inactivity, sleep and metabolic risk factors, though patients may have diverse body sizes and backgrounds.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Insulin resistance increases insulin requirements, while progressive beta-cell dysfunction reduces the pancreas’s ability to compensate. Chronic hyperglycaemia promotes glycation, oxidative stress and microvascular and macrovascular injury.
- Often asymptomatic; polyuria, polydipsia, recurrent infection, fatigue, blurred vision and slow wound healing may occur.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
HbA1c or plasma glucose testing; assess renal function, urine albumin, lipids, eyes, feet and cardiovascular risk.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Nutrition, physical activity, weight management when appropriate and glucose-lowering medicines. Metformin, SGLT2 inhibitors, GLP-1 receptor agonists, other agents and insulin are selected according to comorbidity and glycaemic need.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor glucose trends and symptoms; teach medicines and hypoglycaemia risk; perform/teach foot assessment; support realistic nutrition/activity goals; reinforce eye, renal and cardiovascular screening.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Chronic metabolic disease characterised by insulin resistance and progressive beta-cell dysfunction causing hyperglycaemia.
- Track glucose/HbA1c, blood pressure, lipids, kidney function, urine albumin, foot status and eye screening.
- Treatment should also address cardiovascular and renal risk.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Medication-induced hyperglycaemia, endocrine disorders and type 1/monogenic diabetes should be considered when presentation is atypical. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Track glucose/HbA1c, blood pressure, lipids, kidney function, urine albumin, foot status and eye screening. Treatment should also address cardiovascular and renal risk. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hyperosmolar state, cardiovascular disease, neuropathy, nephropathy, retinopathy and diabetic foot disease.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
DIABETIC KETOACIDOSIS
Acute life-threatening complication of insulin deficiency causing hyperglycaemia, ketosis and metabolic acidosis.
Acute life-threatening complication of insulin deficiency causing hyperglycaemia, ketosis and metabolic acidosis.
Diabetic Ketoacidosis is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Often triggered by missed insulin, infection, new-onset type 1 diabetes, myocardial infarction or other physiological stress.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Severe insulin deficiency allows unchecked lipolysis and hepatic ketone production, causing high-anion-gap metabolic acidosis. Osmotic diuresis from hyperglycaemia produces profound water and electrolyte losses. Serum potassium may initially appear normal or high despite total-body depletion.
- Polyuria, polydipsia, dehydration, nausea/vomiting, abdominal pain, deep respirations, acetone-like breath and altered consciousness.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Blood glucose, blood ketones, venous/arterial blood gas, electrolytes, renal function, ECG and evaluation for the trigger.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Protocol-based IV fluids, insulin and careful potassium/electrolyte replacement, plus treatment of the precipitating cause. Close biochemical monitoring is essential.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent vital signs, neurological status, glucose and ketone monitoring; strict fluid balance; cardiac monitoring when potassium is abnormal; verify infusion rates and lab trends; watch for hypoglycaemia, hypokalaemia and cerebral oedema warning signs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute life-threatening complication of insulin deficiency causing hyperglycaemia, ketosis and metabolic acidosis.
- Frequent glucose, ketones, potassium, bicarbonate/pH, fluid balance and neurological status are required.
- Potassium shifts during treatment can be dangerous.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Starvation ketosis, alcoholic ketoacidosis, lactic acidosis and toxic ingestions can produce metabolic acidosis with overlapping features. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Frequent glucose, ketones, potassium, bicarbonate/pH, fluid balance and neurological status are required. Potassium shifts during treatment can be dangerous. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hypokalaemia, arrhythmia, cerebral oedema, acute kidney injury, shock and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HYPEROSMOLAR HYPERGLYCAEMIC STATE
Severe hyperglycaemic emergency characterised by extreme hyperglycaemia, hyperosmolality and profound dehydration with minimal ketosis compared with DKA.
Severe hyperglycaemic emergency characterised by extreme hyperglycaemia, hyperosmolality and profound dehydration with minimal ketosis compared with DKA.
Hyperosmolar Hyperglycaemic State is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Usually occurs in type 2 diabetes and is often precipitated by infection, inadequate medication, dehydration, stroke or myocardial infarction.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Relative insulin deficiency allows extreme hyperglycaemia without the same degree of ketogenesis seen in DKA. Severe osmotic diuresis causes dehydration and hyperosmolality, which can produce marked neurological dysfunction.
- Marked dehydration, weakness, polyuria initially, confusion, seizures or coma.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Glucose, measured/calculated osmolality, electrolytes, renal function, ketones, blood gas and investigation of precipitating illness.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Careful IV fluid replacement is central, with insulin introduced according to protocol, electrolyte correction and treatment of the trigger; thrombosis risk may require prophylaxis based on clinical protocols.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent neurological, haemodynamic and glucose assessment; strict intake/output; monitor sodium, potassium and osmolality trends; protect confused patients from falls/aspiration; monitor for fluid overload in frail patients.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Severe hyperglycaemic emergency characterised by extreme hyperglycaemia, hyperosmolality and profound dehydration with minimal ketosis compared with DKA.
- Monitor neurological status, osmolality, sodium, potassium, renal function and haemodynamics.
- Correction must be gradual enough to avoid dangerous osmotic shifts.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
DKA, stroke, sepsis and other causes of altered consciousness should be evaluated concurrently. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor neurological status, osmolality, sodium, potassium, renal function and haemodynamics. Correction must be gradual enough to avoid dangerous osmotic shifts. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Thrombosis, seizures, arrhythmia, shock, AKI and neurological injury from overly rapid osmotic change.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HYPOTHYROIDISM
Insufficient thyroid hormone production or action, commonly from autoimmune thyroiditis or treatment of previous thyroid disease.
Insufficient thyroid hormone production or action, commonly from autoimmune thyroiditis or treatment of previous thyroid disease.
Hypothyroidism is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Hashimoto thyroiditis, iodine imbalance, thyroid surgery/radioiodine, pituitary disease and some medicines.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Insufficient thyroid hormone slows metabolic processes across multiple organ systems. In primary hypothyroidism, thyroid gland failure raises TSH through loss of negative feedback. Severe longstanding deficiency can impair ventilation, cardiac function and mental status.
- Fatigue, cold intolerance, dry skin, constipation, weight gain, bradycardia, slow thinking and menstrual changes.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
TSH and free T4 distinguish primary from central patterns; thyroid antibodies may support autoimmune diagnosis.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Thyroid hormone replacement with dose adjusted to clinical status and laboratory monitoring.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor pulse, temperature, weight, bowel function and cognition; teach consistent medication timing and follow-up testing; watch for overtreatment symptoms such as palpitations or tremor.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Insufficient thyroid hormone production or action, commonly from autoimmune thyroiditis or treatment of previous thyroid disease.
- Monitor symptoms, pulse, weight and TSH/free T4 response to therapy.
- Excess replacement can produce palpitations, tremor or iatrogenic hyperthyroidism.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Anaemia, depression, chronic fatigue and medication effects may mimic hypothyroid symptoms. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor symptoms, pulse, weight and TSH/free T4 response to therapy. Excess replacement can produce palpitations, tremor or iatrogenic hyperthyroidism. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Dyslipidaemia, infertility, pericardial effusion and rarely myxoedema coma.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HYPERTHYROIDISM / THYROTOXICOSIS
Excess thyroid hormone action; Graves disease is a common cause of endogenous hyperthyroidism.
Excess thyroid hormone action; Graves disease is a common cause of endogenous hyperthyroidism.
Hyperthyroidism / Thyrotoxicosis is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Graves disease, toxic multinodular goitre, toxic adenoma and thyroiditis.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Excess thyroid hormone increases metabolic rate and amplifies beta-adrenergic effects. Cardiac output rises, heart rate increases and catabolism can cause weight loss and muscle wasting. Graves disease also causes autoimmune orbital and sometimes dermal manifestations.
- Weight loss, heat intolerance, tremor, anxiety, palpitations, diarrhoea, proximal weakness and atrial fibrillation; Graves disease may cause eye signs.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Suppressed TSH with elevated free T4/T3; antibodies and radionuclide/ultrasound assessment may define the cause.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Beta-blockade for symptoms, antithyroid medicines, radioactive iodine or surgery according to cause and patient factors.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor pulse, rhythm, temperature and weight; provide calm environment and adequate nutrition; administer antithyroid therapy and monitor for serious adverse effects such as fever/sore throat suggesting agranulocytosis; recognise thyroid storm as an emergency.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Excess thyroid hormone action; Graves disease is a common cause of endogenous hyperthyroidism.
- Monitor heart rate/rhythm, temperature, weight and signs of heart failure.
- Fever, delirium, severe tachycardia and cardiovascular instability may indicate thyroid storm.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Anxiety disorders, stimulant exposure, infection and other causes of tachycardia and weight loss can mimic thyrotoxicosis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor heart rate/rhythm, temperature, weight and signs of heart failure. Fever, delirium, severe tachycardia and cardiovascular instability may indicate thyroid storm. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Atrial fibrillation, heart failure, osteoporosis and thyroid storm.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PRIMARY ADRENAL INSUFFICIENCY (ADDISON DISEASE)
Deficiency of adrenal glucocorticoids and often mineralocorticoids due to primary adrenal cortex failure.
Deficiency of adrenal glucocorticoids and often mineralocorticoids due to primary adrenal cortex failure.
Primary Adrenal Insufficiency (Addison Disease) is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Autoimmune adrenalitis is common; infections, haemorrhage, metastasis and genetic disorders are other causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Destruction of the adrenal cortex causes cortisol deficiency and often aldosterone deficiency. Loss of cortisol impairs vascular responsiveness and stress adaptation, while aldosterone loss promotes sodium wasting, volume depletion and hyperkalaemia. High ACTH levels cause hyperpigmentation.
- Fatigue, weight loss, hypotension, hyperpigmentation, salt craving, abdominal symptoms, hyponatraemia and hyperkalaemia.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Morning cortisol, ACTH and stimulation testing, electrolytes and investigation for the cause.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Lifelong glucocorticoid replacement and usually mineralocorticoid replacement. Adrenal crisis requires urgent IV glucocorticoid and fluid resuscitation.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor BP, weight and electrolytes; teach never to stop steroids abruptly; reinforce sick-day dose adjustment per clinical plan and emergency steroid identification; recognise vomiting, severe weakness, hypotension or confusion as crisis signs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Deficiency of adrenal glucocorticoids and often mineralocorticoids due to primary adrenal cortex failure.
- Monitor blood pressure, sodium, potassium, glucose and volume status.
- Vomiting, hypotension or acute illness may precipitate adrenal crisis.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Chronic GI disease, depression, weight-loss disorders and other endocrine diseases can resemble Addison disease. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor blood pressure, sodium, potassium, glucose and volume status. Vomiting, hypotension or acute illness may precipitate adrenal crisis. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Adrenal crisis, shock, severe electrolyte disturbance and hypoglycaemia.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
CUSHING SYNDROME
Clinical state caused by chronic excess glucocorticoid exposure, either endogenous or from prolonged corticosteroid therapy.
Clinical state caused by chronic excess glucocorticoid exposure, either endogenous or from prolonged corticosteroid therapy.
Cushing Syndrome is best understood by first relating it to normal endocrine & metabolic physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Exogenous steroids are common; endogenous causes include pituitary ACTH adenoma, ectopic ACTH production and adrenal tumours.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Chronic glucocorticoid excess promotes protein catabolism, gluconeogenesis, insulin resistance, central fat redistribution, bone loss and immunosuppression. Mineralocorticoid effects contribute to hypertension and electrolyte disturbances.
- Central weight gain, facial rounding, thin skin, easy bruising, proximal muscle weakness, hypertension, glucose intolerance, osteoporosis and mood changes.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Biochemical screening for cortisol excess followed by tests to identify the source; review exogenous steroid use carefully.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the cause, which may involve gradual steroid reduction when medically appropriate, surgery, radiotherapy or cortisol-lowering medicines.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor BP, glucose, skin integrity and infection; use gentle handling due to bruising/bone fragility; support nutrition and mobility; reinforce that long-term corticosteroids must not be stopped suddenly.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Clinical state caused by chronic excess glucocorticoid exposure, either endogenous or from prolonged corticosteroid therapy.
- Monitor blood pressure, glucose, infection, skin integrity, mood and bone risk.
- Patients exposed to chronic glucocorticoids must not stop them abruptly.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Simple obesity, metabolic syndrome, alcoholism and severe depression can produce overlapping phenotypic features. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor glucose, electrolytes, fluid balance, vital signs and mental state according to the severity of disease. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Coordinate medicines with meals and monitoring where relevant, and watch for hypoglycaemia or endocrine overtreatment. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sick-day and emergency protocols exactly as prescribed for diabetes or adrenal disease. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Assess cardiovascular status because endocrine disorders frequently affect heart rate, blood pressure and rhythm. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration and self-management education using clear written plans. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate severe hypo/hyperglycaemia, shock, arrhythmia, altered consciousness or suspected endocrine crisis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor blood pressure, glucose, infection, skin integrity, mood and bone risk. Patients exposed to chronic glucocorticoids must not stop them abruptly. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take hormone or glucose-lowering treatment exactly as prescribed, keep monitoring records when advised, learn condition-specific sick-day rules, carry emergency identification when appropriate, and recognise symptoms of severe hypo/hyperglycaemia or adrenal/thyroid emergency.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Diabetes, hypertension, infection, thrombosis, osteoporosis, fractures and cardiovascular disease.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for unstable blood glucose
- Deficient fluid volume
- Risk for electrolyte imbalance
- Fatigue
- Deficient knowledge
Improvement is reflected by stable glucose/electrolytes, haemodynamic stability, improved symptoms and the patient’s ability to explain safe self-management. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ISCHAEMIC STROKE
Acute neurological deficit caused by focal cerebral infarction due to arterial occlusion.
Acute neurological deficit caused by focal cerebral infarction due to arterial occlusion.
Ischaemic Stroke is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Large-artery atherosclerosis, cardioembolism, small-vessel disease and other vascular causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Arterial occlusion abruptly reduces cerebral blood flow. The infarct core undergoes irreversible injury, while surrounding penumbral tissue may remain salvageable for a limited period if reperfusion is restored. This underlies the time-critical nature of stroke treatment.
- Sudden facial weakness, arm/leg weakness or numbness, speech disturbance, visual loss, ataxia or neglect.
- Symptoms depend on vascular territory.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urgent non-contrast CT or MRI to exclude haemorrhage, vascular imaging, glucose, blood tests and ECG; time last known well is essential.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Rapid stroke-pathway assessment, IV thrombolysis for eligible patients within time criteria, mechanical thrombectomy for selected large-vessel occlusions, antiplatelet therapy after haemorrhage is excluded and secondary prevention.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Activate stroke protocol; document onset/last-known-well; maintain airway and oxygenation, check glucose, keep NPO until swallow screen, monitor neurological status/BP, prevent aspiration and pressure injury, begin rehabilitation and communication support early.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute neurological deficit caused by focal cerebral infarction due to arterial occlusion.
- Record last-known-well time, perform serial neurological observations, monitor glucose, blood pressure, swallow safety and oxygenation.
- Sudden deterioration may reflect cerebral oedema, haemorrhagic transformation or recurrent stroke.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Hypoglycaemia, seizure with postictal weakness, migraine, intracranial haemorrhage and functional neurological disorder can mimic stroke. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Record last-known-well time, perform serial neurological observations, monitor glucose, blood pressure, swallow safety and oxygenation. Sudden deterioration may reflect cerebral oedema, haemorrhagic transformation or recurrent stroke. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Cerebral oedema, aspiration pneumonia, DVT, pressure injury, seizures, depression and long-term disability.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HAEMORRHAGIC STROKE
Neurological injury caused by bleeding into brain tissue or the subarachnoid space.
Neurological injury caused by bleeding into brain tissue or the subarachnoid space.
Haemorrhagic Stroke is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Hypertension, cerebral aneurysm, arteriovenous malformation, cerebral amyloid angiopathy and anticoagulation are important causes.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Rupture of a cerebral vessel causes direct tissue destruction and an expanding haematoma. Mass effect raises intracranial pressure and can reduce cerebral perfusion. In subarachnoid haemorrhage, blood in the subarachnoid space can trigger vasospasm and hydrocephalus.
- Sudden focal deficit, severe headache, vomiting, reduced consciousness or seizures; subarachnoid haemorrhage may present with abrupt 'thunderclap' headache.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urgent non-contrast CT, vascular imaging and coagulation studies; lumbar puncture may be considered for suspected SAH when imaging is nondiagnostic and clinically appropriate.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Neurospecialist care, controlled BP management, reversal of anticoagulation when appropriate, treatment of raised intracranial pressure and surgical/endovascular intervention for selected lesions.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent neurological observations and airway assessment; head elevation if prescribed; minimise avoidable stimulation when ICP is a concern; seizure precautions; careful fluid balance; monitor for sudden deterioration.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Neurological injury caused by bleeding into brain tissue or the subarachnoid space.
- Frequent neurological assessment, airway protection, blood pressure monitoring and observation for signs of rising intracranial pressure are essential.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
- Raised intracranial pressure, herniation, hydrocephalus, vasospasm after SAH, seizures and disability.
Ischaemic stroke cannot be reliably distinguished clinically; urgent brain imaging is required. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Frequent neurological assessment, airway protection, blood pressure monitoring and observation for signs of rising intracranial pressure are essential. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Raised intracranial pressure, herniation, hydrocephalus, vasospasm after SAH, seizures and disability.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
EPILEPSY
A brain disorder characterised by an enduring predisposition to recurrent unprovoked seizures.
A brain disorder characterised by an enduring predisposition to recurrent unprovoked seizures.
Epilepsy is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Genetic, structural, metabolic, immune, infectious or unknown causes; individual seizures may also be provoked by acute illness.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Epilepsy reflects a persistent tendency of neuronal networks to generate abnormal synchronous electrical discharges. Manifestations depend on where the discharge begins and how it spreads through the brain.
- Focal or generalised seizures, altered awareness, motor activity, sensory phenomena or postictal confusion depending on seizure type.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
History/witness account, EEG, brain imaging when indicated and laboratory evaluation for provoked causes.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Antiseizure medication selected by seizure type and patient factors; surgery, neuromodulation or ketogenic dietary therapy may be used for selected drug-resistant epilepsy.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
During a seizure protect from injury, clear nearby hazards, place on side when feasible, time the event and do not restrain or put objects in the mouth; assess airway/breathing afterward; document features and triggers; reinforce medication adherence and safety planning.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- A brain disorder characterised by an enduring predisposition to recurrent unprovoked seizures.
- During events, time the seizure and document motor, sensory and awareness features.
- Prolonged or repeated seizures without recovery may indicate status epilepticus.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Syncope, psychogenic non-epileptic events, hypoglycaemia, movement disorders and transient ischaemic attacks may resemble seizures. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
During events, time the seizure and document motor, sensory and awareness features. Prolonged or repeated seizures without recovery may indicate status epilepticus. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Status epilepticus, trauma, aspiration, medication adverse effects and psychosocial consequences.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
MENINGITIS
Inflammation of the meninges, most importantly caused by bacterial or viral infection; bacterial meningitis is a medical emergency.
Inflammation of the meninges, most importantly caused by bacterial or viral infection; bacterial meningitis is a medical emergency.
Meningitis is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common bacterial causes vary by age and risk, including Streptococcus pneumoniae and Neisseria meningitidis; viruses are also common.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Inflammation of the meninges is caused by bacterial, viral or other infectious processes. Bacterial meningitis can rapidly increase intracranial pressure, disrupt the blood–brain barrier and provoke systemic sepsis.
- Fever, severe headache, neck stiffness, photophobia, vomiting and altered mental state; rash may occur in meningococcal disease.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Blood cultures, urgent lumbar puncture when safe, CSF analysis and neuroimaging first when specific raised-ICP or focal-neurology concerns exist.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Immediate empiric IV antibiotics for suspected bacterial meningitis without unnecessary delay, with adjunct corticosteroid in appropriate cases and pathogen-directed treatment thereafter.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Use appropriate droplet precautions for suspected meningococcal disease; frequent neurological/vital-sign monitoring; reduce environmental stimulation; seizure precautions; administer antimicrobials on time; monitor fluid/electrolyte balance.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inflammation of the meninges, most importantly caused by bacterial or viral infection; bacterial meningitis is a medical emergency.
- Monitor GCS, pupils, seizures, temperature and haemodynamics.
- Treatment for suspected bacterial meningitis should not be delayed unnecessarily for investigations.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Encephalitis, subarachnoid haemorrhage, severe migraine and systemic infection can cause headache, fever or altered consciousness. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor GCS, pupils, seizures, temperature and haemodynamics. Treatment for suspected bacterial meningitis should not be delayed unnecessarily for investigations. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Sepsis, hearing loss, seizures, hydrocephalus, neurological disability and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ENCEPHALITIS
Inflammation of brain parenchyma, often infectious or autoimmune, causing altered brain function.
Inflammation of brain parenchyma, often infectious or autoimmune, causing altered brain function.
Encephalitis is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Viruses such as herpes simplex are important infectious causes; autoimmune encephalitis is another major category.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Inflammation of brain parenchyma causes neuronal dysfunction and cerebral oedema. Viral infection—especially HSV—or autoimmune processes are important causes. Temporal-lobe involvement in HSV encephalitis can produce behavioural change, memory disturbance and seizures.
- Fever, headache, altered behaviour or consciousness, seizures, focal deficits and memory disturbance.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
MRI brain, CSF studies, EEG and pathogen/autoimmune testing according to clinical suspicion.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Empiric IV aciclovir is commonly started promptly when HSV encephalitis is suspected while diagnostic testing proceeds; supportive care and cause-specific therapy follow.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent neurological observations, airway protection, seizure precautions, fluid/electrolyte monitoring and low-stimulation care; monitor IV antiviral renal effects and ensure hydration as prescribed.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inflammation of brain parenchyma, often infectious or autoimmune, causing altered brain function.
- Frequent neurological observations, seizure monitoring and airway assessment are central.
- Rising intracranial pressure or refractory seizures require critical-care escalation.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Meningitis, toxic-metabolic encephalopathy, stroke, brain tumour and psychiatric disease can present with altered behaviour or consciousness. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Frequent neurological observations, seizure monitoring and airway assessment are central. Rising intracranial pressure or refractory seizures require critical-care escalation. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Seizures, cerebral oedema, cognitive impairment, behavioural changes and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PARKINSON DISEASE
Progressive neurodegenerative disorder characterised by bradykinesia plus rigidity and/or resting tremor, with many non-motor features.
Progressive neurodegenerative disorder characterised by bradykinesia plus rigidity and/or resting tremor, with many non-motor features.
Parkinson Disease is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Loss of dopaminergic neurons in the substantia nigra; most cases are idiopathic with genetic/environmental contributions.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Degeneration of dopaminergic neurones in the substantia nigra reduces dopamine delivery to basal ganglia circuits. This disrupts movement initiation and scaling, producing bradykinesia, rigidity and tremor. Non-motor autonomic and cognitive features reflect wider neurodegeneration.
- Bradykinesia, rigidity, resting tremor, shuffling gait, postural instability, constipation, sleep disturbance, depression and autonomic symptoms.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Primarily clinical; imaging may exclude alternative diagnoses.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Dopaminergic therapy such as levodopa, dopamine agonists or MAO-B inhibitors according to symptoms; physiotherapy, occupational therapy and selected deep-brain stimulation.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Give time-critical Parkinson medicines on schedule; assess swallowing and aspiration risk; support mobility and fall prevention; encourage exercise and bowel regimen; monitor orthostatic hypotension, hallucinations and medication fluctuations.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Progressive neurodegenerative disorder characterised by bradykinesia plus rigidity and/or resting tremor, with many non-motor features.
- Time-critical administration of dopaminergic medication is essential.
- Monitor swallowing, falls, orthostatic hypotension, hallucinations and motor fluctuations.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Drug-induced parkinsonism, essential tremor, vascular parkinsonism and atypical neurodegenerative syndromes may resemble Parkinson disease. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Time-critical administration of dopaminergic medication is essential. Monitor swallowing, falls, orthostatic hypotension, hallucinations and motor fluctuations. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Falls, aspiration pneumonia, dementia, dysphagia and medication-related dyskinesia.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
MULTIPLE SCLEROSIS
Chronic immune-mediated inflammatory demyelinating disease of the central nervous system with episodes or progression of neurological dysfunction.
Chronic immune-mediated inflammatory demyelinating disease of the central nervous system with episodes or progression of neurological dysfunction.
Multiple Sclerosis is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Multifactorial autoimmune disease influenced by genetic and environmental factors.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Immune-mediated inflammation damages CNS myelin and axons. Lesions scattered in space and time disrupt conduction in different neural pathways, explaining the variable combination of visual, sensory, motor and autonomic symptoms.
- Optic neuritis, sensory symptoms, limb weakness, diplopia, imbalance, fatigue and bladder dysfunction; symptoms vary by lesion site.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
MRI brain/spinal cord, CSF oligoclonal bands and clinical evidence of dissemination in time and space.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
High-dose corticosteroid for significant acute relapses and disease-modifying therapy to reduce future activity; rehabilitation and symptomatic treatment.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess fatigue, mobility, vision, continence and skin; pace activities and prevent overheating if temperature worsens symptoms; reinforce medication monitoring; support bladder/bowel plans and multidisciplinary rehabilitation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Chronic immune-mediated inflammatory demyelinating disease of the central nervous system with episodes or progression of neurological dysfunction.
- Assess mobility, fatigue, vision, continence, skin and mood.
- Disease-modifying therapies require infection and laboratory monitoring.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Neuromyelitis optica spectrum disorders, B12 deficiency, structural spinal disease and vascular lesions may mimic MS. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess mobility, fatigue, vision, continence, skin and mood. Disease-modifying therapies require infection and laboratory monitoring. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Mobility impairment, falls, spasticity, chronic pain, bladder dysfunction and cognitive/mood problems.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
GUILLAIN–BARRÉ SYNDROME
Acute immune-mediated polyradiculoneuropathy causing rapidly progressive weakness and reduced reflexes, often after infection.
Acute immune-mediated polyradiculoneuropathy causing rapidly progressive weakness and reduced reflexes, often after infection.
Guillain–Barré Syndrome is best understood by first relating it to normal neurological physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Frequently follows gastrointestinal or respiratory infection, including Campylobacter jejuni; exact immune mechanisms vary.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
An immune response—often triggered by infection—targets peripheral nerve myelin or axons. Conduction failure produces ascending weakness and areflexia. Autonomic nerves may also be affected, causing dangerous blood pressure and rhythm instability.
- Symmetrical ascending weakness, areflexia, paraesthesia, facial/bulbar weakness and autonomic instability.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical examination, nerve-conduction studies and CSF showing elevated protein with relatively few cells after the early phase; monitor respiratory function serially.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
IV immunoglobulin or plasma exchange; meticulous respiratory, autonomic and supportive care. Corticosteroids are not effective as sole therapy for typical GBS.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Serial respiratory assessment including vital capacity where available; continuous cardiac/BP monitoring in significant disease; aspiration precautions; DVT/pressure-area prevention; pain relief, eye care if facial weakness and communication support.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Acute immune-mediated polyradiculoneuropathy causing rapidly progressive weakness and reduced reflexes, often after infection.
- Serial respiratory function, bulbar function, heart rate and blood pressure are essential because deterioration can be rapid even before obvious respiratory distress.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
- Respiratory failure, aspiration, arrhythmia, severe BP instability, DVT and prolonged weakness.
Spinal cord compression, myasthenia gravis, botulism and electrolyte disorders can produce acute weakness. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Perform serial neurological observations using a consistent scale and document changes promptly. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Protect airway and perform swallow screening or aspiration precautions when consciousness or bulbar function is impaired. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Institute seizure, falls and pressure-injury precautions according to risk. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Support mobility, communication and rehabilitation while avoiding unnecessary overstimulation in acute brain injury. Rationale: Identifies complications before they become clinically advanced.
- Administer neurological medicines on time and monitor sedation, adverse effects and functional response. Rationale: Reduces preventable hospital complications and supports recovery.
- Escalate new focal deficit, declining consciousness, prolonged seizure, unequal pupils or signs of raised intracranial pressure. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Serial respiratory function, bulbar function, heart rate and blood pressure are essential because deterioration can be rapid even before obvious respiratory distress. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Take neurological medicines on schedule, use falls and seizure precautions when applicable, follow swallowing and mobility recommendations, avoid driving or hazardous activity when medically restricted, and report new weakness, speech change, seizures, reduced consciousness, or severe sudden headache immediately.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Respiratory failure, aspiration, arrhythmia, severe BP instability, DVT and prolonged weakness.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for aspiration
- Impaired physical mobility
- Acute confusion
- Risk for injury
- Impaired verbal communication
Desired outcomes include stable or improving neurological examination, safe swallowing, absence of injury, improved function and effective communication strategies. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
IRON-DEFICIENCY ANAEMIA
Anaemia caused by inadequate iron availability for haemoglobin synthesis, resulting in microcytic hypochromic red cells in established disease.
Anaemia caused by inadequate iron availability for haemoglobin synthesis, resulting in microcytic hypochromic red cells in established disease.
Iron-Deficiency Anaemia is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Blood loss, increased demand, inadequate intake or malabsorption.
- In adults, unexplained iron deficiency should prompt evaluation for blood loss.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Insufficient iron limits haem synthesis, reducing haemoglobin production and eventually producing microcytic, hypochromic red cells. Tissue oxygen delivery falls, leading to fatigue and exertional symptoms.
- Fatigue, pallor, exertional dyspnoea, dizziness, palpitations, pica and sometimes brittle nails.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Full blood count, ferritin and iron studies; investigate gastrointestinal, menstrual or other sources of blood loss as appropriate.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Oral or IV iron replacement depending on severity/tolerance and treatment of the underlying cause.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess fatigue and exercise tolerance; teach iron therapy administration and common GI effects; encourage iron-rich diet; monitor haemoglobin/ferritin response; reinforce investigation of bleeding rather than iron replacement alone.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Anaemia caused by inadequate iron availability for haemoglobin synthesis, resulting in microcytic hypochromic red cells in established disease.
- Track haemoglobin, ferritin and treatment response while investigating the cause of iron loss.
- Failure to respond should prompt review of adherence, absorption, diagnosis or ongoing bleeding.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Thalassaemia, anaemia of chronic disease and sideroblastic anaemia can also cause microcytosis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Track haemoglobin, ferritin and treatment response while investigating the cause of iron loss. Failure to respond should prompt review of adherence, absorption, diagnosis or ongoing bleeding. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Reduced functional capacity, pregnancy complications, developmental effects in children and cardiac strain in severe chronic anaemia.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
SICKLE CELL DISEASE
Inherited haemoglobin disorder in which haemoglobin S polymerises under stress, causing chronic haemolysis and recurrent vaso-occlusion.
Inherited haemoglobin disorder in which haemoglobin S polymerises under stress, causing chronic haemolysis and recurrent vaso-occlusion.
Sickle Cell Disease is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Autosomal recessive HBB variants; sickling is promoted by dehydration, hypoxia, acidosis, infection and other physiological stress.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Deoxygenated haemoglobin S polymerises, distorting red cells and making them rigid. Repeated sickling causes haemolysis and microvascular obstruction. Inflammation and endothelial activation further worsen vaso-occlusion and progressive organ damage.
- Chronic anaemia, painful vaso-occlusive episodes, jaundice, acute chest syndrome, infections and organ complications.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Haemoglobin analysis confirms diagnosis; full blood count, reticulocytes and organ-specific tests assess complications.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Vaccination and infection prevention, hydroxyurea for many patients, analgesia and hydration during pain episodes, transfusion for selected complications, and specialist disease-modifying/curative therapies in selected patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Treat severe pain promptly according to prescribed plan; assess oxygenation, fever and chest symptoms; encourage hydration where appropriate; use incentive spirometry in admitted pain episodes when prescribed; monitor transfusions and provide psychosocial support.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Inherited haemoglobin disorder in which haemoglobin S polymerises under stress, causing chronic haemolysis and recurrent vaso-occlusion.
- Assess pain, fever, oxygenation and chest symptoms carefully.
- New respiratory symptoms, falling oxygen saturation or chest infiltrate may indicate acute chest syndrome.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Other causes of acute pain, infection, osteomyelitis and acute abdomen may coexist and should not automatically be attributed to a vaso-occlusive episode. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess pain, fever, oxygenation and chest symptoms carefully. New respiratory symptoms, falling oxygen saturation or chest infiltrate may indicate acute chest syndrome. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Acute chest syndrome, stroke, severe infection, splenic sequestration, priapism, chronic kidney disease and avascular necrosis.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
LEUKAEMIA
Malignant clonal disorders of blood-forming tissues causing abnormal proliferation of leukocytes or precursors and suppression of normal marrow function.
Malignant clonal disorders of blood-forming tissues causing abnormal proliferation of leukocytes or precursors and suppression of normal marrow function.
Leukaemia is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Usually multifactorial; subtypes include acute lymphoblastic, acute myeloid, chronic lymphocytic and chronic myeloid leukaemias.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Clonal proliferation of abnormal haematopoietic cells crowds the marrow and impairs normal production of red cells, platelets and functional leukocytes. Acute leukaemias can progress rapidly, while chronic forms may evolve more slowly.
- Fatigue, pallor, fever/infection, bruising/bleeding, bone pain, lymphadenopathy and weight loss.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Full blood count and film, bone-marrow examination, flow cytometry and cytogenetic/molecular testing.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Subtype-specific chemotherapy, targeted therapy, immunotherapy and/or stem-cell transplantation; supportive transfusion and infection prevention are central.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Neutropenic infection surveillance, bleeding precautions, oral care, nausea management, central-line care, tumour-lysis monitoring, psychosocial support and safe handling of hazardous medicines according to institutional policy.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Malignant clonal disorders of blood-forming tissues causing abnormal proliferation of leukocytes or precursors and suppression of normal marrow function.
- Monitor infection, bleeding, blood counts, tumour lysis markers and treatment toxicities.
- Fever in severe neutropenia is an oncological emergency.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Severe infection, aplastic anaemia, lymphoma and other marrow disorders may produce cytopenias or constitutional symptoms. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor infection, bleeding, blood counts, tumour lysis markers and treatment toxicities. Fever in severe neutropenia is an oncological emergency. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Severe infection, bleeding, tumour lysis syndrome, anaemia, organ infiltration and treatment toxicities.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
THROMBOCYTOPENIA
Platelet count below the normal range due to reduced production, increased destruction/consumption or sequestration.
Platelet count below the normal range due to reduced production, increased destruction/consumption or sequestration.
Thrombocytopenia is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Drug effects, immune thrombocytopenia, infection, marrow disease, liver disease, DIC and thrombotic microangiopathies are examples.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Low platelet count results from reduced marrow production, increased immune or non-immune destruction, consumption, dilution or splenic sequestration. Bleeding risk generally rises as the count falls, but the clinical context also matters.
- Petechiae, purpura, mucosal bleeding, easy bruising or no symptoms; severe cases may develop major bleeding.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Repeat full blood count, peripheral film, coagulation profile and targeted testing based on cause; exclude pseudothrombocytopenia.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Treat the cause; immune thrombocytopenia may require corticosteroids or IVIG, and platelet transfusion is reserved for selected bleeding/procedure contexts.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Inspect skin/mucosa for bleeding; avoid unnecessary IM injections and traumatic procedures; use soft oral care; apply prolonged pressure after venepuncture; monitor stool/urine and neurological symptoms; review medicines affecting platelets.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Platelet count below the normal range due to reduced production, increased destruction/consumption or sequestration.
- Inspect for petechiae, mucosal bleeding, GI or urinary bleeding and neurological symptoms.
- Avoid unnecessary invasive procedures when platelet count is severely reduced.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Laboratory platelet clumping can cause pseudothrombocytopenia and should be excluded. DIC, TTP/HUS and immune thrombocytopenia require different urgent approaches. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Inspect for petechiae, mucosal bleeding, GI or urinary bleeding and neurological symptoms. Avoid unnecessary invasive procedures when platelet count is severely reduced. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Major haemorrhage including gastrointestinal or intracranial bleeding.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
SEPSIS
Life-threatening organ dysfunction caused by a dysregulated host response to infection.
Life-threatening organ dysfunction caused by a dysregulated host response to infection.
Sepsis is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Bacterial infection is common, but viral, fungal and other infections can cause sepsis.
- Frequent sources include lung, urinary tract, abdomen, skin and bloodstream.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Sepsis is a dysregulated host response to infection that causes endothelial injury, vasodilation, capillary leak, microcirculatory dysfunction and organ injury. In septic shock, circulatory and metabolic abnormalities persist despite initial resuscitation.
- Fever or hypothermia, tachycardia, tachypnoea, hypotension, altered mental state, reduced urine output and signs of the infection source.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Urgent clinical assessment, lactate, blood cultures before antibiotics when this does not cause delay, full blood count, renal/liver tests, imaging and source cultures as indicated.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Rapid antimicrobials for suspected bacterial sepsis, IV fluids for hypoperfusion, vasopressors if hypotension persists, oxygen/ventilatory support and urgent source control.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Recognise deterioration early; perform frequent vital signs and mental-status checks; measure urine output; obtain cultures promptly; give prescribed antimicrobials and fluids without avoidable delay; monitor response, lactate trend and signs of overload.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Life-threatening organ dysfunction caused by a dysregulated host response to infection.
- Frequent vital signs, mental state, urine output, lactate trend and perfusion assessment are central.
- Delays in antimicrobials or source control can worsen outcomes.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Haemorrhage, cardiogenic shock, anaphylaxis and other causes of systemic inflammatory response can mimic sepsis. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Frequent vital signs, mental state, urine output, lactate trend and perfusion assessment are central. Delays in antimicrobials or source control can worsen outcomes. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Septic shock, ARDS, AKI, DIC, myocardial dysfunction, multi-organ failure and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
HIV INFECTION / AIDS
Chronic infection with human immunodeficiency virus causing progressive immune dysfunction if untreated. AIDS refers to advanced immune suppression or defining clinical conditions.
Chronic infection with human immunodeficiency virus causing progressive immune dysfunction if untreated. AIDS refers to advanced immune suppression or defining clinical conditions.
HIV Infection / AIDS is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Transmission occurs through specific body fluids, including sexual exposure, blood exposure and vertical transmission.
- HIV is not transmitted by ordinary casual contact.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
HIV infects CD4 T lymphocytes and progressively impairs cell-mediated immunity if untreated. Effective antiretroviral therapy suppresses viral replication, allows immune recovery and markedly reduces morbidity, mortality and transmission risk.
- Acute retroviral illness may resemble a viral syndrome; chronic infection may be asymptomatic for years; advanced disease predisposes to opportunistic infection and malignancy.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Validated antigen/antibody testing algorithms with confirmatory testing; viral load and CD4 count guide monitoring.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Combination antiretroviral therapy is recommended for all people with HIV, with prevention and treatment of opportunistic infections and comorbidities.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Use standard precautions without stigma; support adherence and side-effect monitoring; protect confidentiality; reinforce follow-up, vaccination and infection prevention; monitor for opportunistic disease and psychosocial needs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Chronic infection with human immunodeficiency virus causing progressive immune dysfunction if untreated.
- AIDS refers to advanced immune suppression or defining clinical conditions.
- Monitor adherence, viral load, CD4 count when indicated, drug toxicity and symptoms of opportunistic infection.
- Care should be confidential and stigma-free.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Other causes of chronic weight loss, lymphadenopathy and recurrent infection should be considered until HIV is confirmed with validated testing. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor adherence, viral load, CD4 count when indicated, drug toxicity and symptoms of opportunistic infection. Care should be confidential and stigma-free. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Opportunistic infections, malignancies, neurological disease, wasting and cardiovascular/metabolic complications if not effectively treated.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
MALARIA
Mosquito-borne parasitic disease caused by Plasmodium species; Plasmodium falciparum is responsible for most severe malaria in sub-Saharan Africa.
Mosquito-borne parasitic disease caused by Plasmodium species; Plasmodium falciparum is responsible for most severe malaria in sub-Saharan Africa.
Malaria is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Transmission occurs mainly through bites of infected female Anopheles mosquitoes; less commonly via blood exposure or congenital transmission.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Plasmodium parasites undergo liver-stage development before infecting red blood cells. Cyclical erythrocyte invasion and rupture cause fever and haemolysis. P. falciparum can cause microvascular sequestration, leading to cerebral malaria, acidosis and organ failure.
- Fever, chills, headache, malaise, myalgia, nausea and anaemia.
- Severe malaria may cause impaired consciousness, seizures, severe anaemia, hypoglycaemia, acidosis, jaundice or kidney injury.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Parasitological confirmation with rapid diagnostic test and/or microscopy when available; assess glucose, haemoglobin, renal function and severity features.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Antimalarial treatment depends on species, severity, pregnancy status and local/national guidelines. Severe malaria requires urgent parenteral therapy and supportive management.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Monitor temperature, neurological status, glucose, urine output and hydration; administer antimalarials exactly as prescribed; manage fever and anaemia; watch for severe-malaria signs; reinforce insecticide-treated net use and prevention.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Mosquito-borne parasitic disease caused by Plasmodium species; Plasmodium falciparum is responsible for most severe malaria in sub-Saharan Africa.
- Monitor temperature, consciousness, glucose, urine output, haemoglobin and signs of severe malaria.
- Hypoglycaemia and neurological deterioration can occur rapidly.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Typhoid fever, dengue, bacterial sepsis, meningitis and other febrile illnesses may mimic malaria. Parasitological confirmation is important whenever feasible. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor temperature, consciousness, glucose, urine output, haemoglobin and signs of severe malaria. Hypoglycaemia and neurological deterioration can occur rapidly. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Cerebral malaria, severe anaemia, hypoglycaemia, AKI, acidosis, shock and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
ANAPHYLAXIS
Rapid-onset systemic hypersensitivity reaction that can cause airway, breathing or circulatory compromise and may include skin/mucosal features.
Rapid-onset systemic hypersensitivity reaction that can cause airway, breathing or circulatory compromise and may include skin/mucosal features.
Anaphylaxis is best understood by first relating it to normal haematology, immunology & infection physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Common triggers include foods, medicines, insect venom and latex; the trigger may be unknown.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Anaphylaxis is a rapid systemic hypersensitivity reaction driven by mast-cell and basophil mediator release. Vasodilation and capillary leak reduce circulating volume, while bronchospasm and upper-airway oedema can obstruct breathing.
- Sudden urticaria/flushing, swelling, wheeze, stridor, hypotension, gastrointestinal symptoms or collapse after exposure.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Diagnosis is clinical and treatment must not wait for tests; serum tryptase may later support diagnosis in selected cases.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Immediate intramuscular adrenaline/epinephrine is first-line, with airway support, oxygen and IV fluids as needed. Adjunctive medicines do not replace adrenaline.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Call for emergency help; position according to circulation/breathing needs; administer prescribed emergency adrenaline promptly; monitor airway, breathing, circulation and rhythm; prepare for repeated doses/advanced airway support; observe for recurrence and document the trigger.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Rapid-onset systemic hypersensitivity reaction that can cause airway, breathing or circulatory compromise and may include skin/mucosal features.
- Continuous reassessment of airway, breathing and circulation is essential.
- Improvement after adrenaline does not eliminate the risk of recurrence, so observation should follow local protocols.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Severe asthma, vasovagal syncope, panic attack and septic shock can mimic parts of the presentation, but anaphylaxis is treated on clinical grounds when criteria are met. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Monitor temperature, full blood count trends, bleeding, perfusion and disease-specific warning signs. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Use standard and transmission-based precautions correctly and protect invasive devices from infection. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Administer antimicrobials, transfusions or disease-modifying therapy safely and observe for reactions. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- Use bleeding precautions when platelet or coagulation abnormalities are present. Rationale: Identifies complications before they become clinically advanced.
- Support nutrition, hydration, pain control and energy conservation. Rationale: Reduces preventable hospital complications and supports recovery.
- Teach when fever, bleeding, chest pain, breathlessness or neurological symptoms require urgent assessment. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Continuous reassessment of airway, breathing and circulation is essential. Improvement after adrenaline does not eliminate the risk of recurrence, so observation should follow local protocols. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Maintain medication and clinic follow-up, practise infection and bleeding precautions when relevant, follow vaccination or prophylaxis advice, maintain adequate nutrition/hydration as advised, and report fever, unusual bleeding, severe breathlessness, chest pain, neurological symptoms, or rapidly worsening weakness.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Airway obstruction, shock, cardiac arrest and biphasic reaction.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Risk for infection
- Risk for bleeding
- Fatigue
- Acute pain
- Ineffective tissue perfusion
Improvement includes control of infection, stable blood counts or haemostasis, adequate perfusion, reduced pain and absence of treatment-related complications. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
OSTEOARTHRITIS
Degenerative whole-joint disorder characterised by cartilage loss, subchondral bone change and variable synovial inflammation.
Degenerative whole-joint disorder characterised by cartilage loss, subchondral bone change and variable synovial inflammation.
Osteoarthritis is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Age, prior injury, joint loading, genetics and some anatomical factors contribute.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Osteoarthritis is a whole-joint disorder involving cartilage degeneration, subchondral bone change, osteophyte formation and variable synovitis. Mechanical loading and impaired tissue repair progressively reduce smooth joint movement.
- Activity-related joint pain, brief morning stiffness, reduced range of motion, crepitus and bony enlargement.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Usually clinical; plain radiographs support diagnosis when needed and help assess alternative causes.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Exercise and physiotherapy, weight management when relevant, topical/oral analgesic strategies, intra-articular options in selected patients and joint replacement for severe refractory disease.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain/function and falls risk; encourage graded exercise and joint protection; teach safe use of analgesics; support assistive devices and perioperative care when joint replacement is planned.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Degenerative whole-joint disorder characterised by cartilage loss, subchondral bone change and variable synovial inflammation.
- Assess pain, mobility, function and falls risk.
- Treatment success is measured by improved function and participation, not only pain scores.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Inflammatory arthritis, crystal arthritis, bursitis and referred pain should be considered when features are atypical. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess pain, mobility, function and falls risk. Treatment success is measured by improved function and participation, not only pain scores. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Reduced mobility, falls, sleep disturbance and functional dependence.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
RHEUMATOID ARTHRITIS
Chronic systemic autoimmune inflammatory arthritis that primarily affects synovial joints and can cause progressive joint destruction.
Chronic systemic autoimmune inflammatory arthritis that primarily affects synovial joints and can cause progressive joint destruction.
Rheumatoid Arthritis is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Autoimmune disease influenced by genetic and environmental factors, including tobacco exposure.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Autoimmune synovial inflammation causes pannus formation, cartilage destruction and bone erosion. Persistent systemic inflammation also raises cardiovascular, osteoporosis and infection risks.
- Symmetrical small-joint pain/swelling, prolonged morning stiffness, fatigue and possible extra-articular disease.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Inflammatory markers, rheumatoid factor, anti-CCP antibodies and imaging; diagnosis is clinical and should not be delayed solely by negative serology.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Early disease-modifying antirheumatic therapy, commonly methotrexate-based where appropriate, with short-term anti-inflammatory treatment and biologic/targeted therapy for selected patients.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain, stiffness, fatigue and function; balance rest with regular movement; monitor DMARD toxicity labs and infection risk; provide joint-protection teaching and vaccination advice; support multidisciplinary rehabilitation.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Chronic systemic autoimmune inflammatory arthritis that primarily affects synovial joints and can cause progressive joint destruction.
- Monitor swollen/tender joints, function, inflammatory markers and DMARD toxicities.
- Infection risk must be considered before and during immunosuppressive therapy.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Osteoarthritis, psoriatic arthritis, lupus and crystal arthritis may resemble RA. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor swollen/tender joints, function, inflammatory markers and DMARD toxicities. Infection risk must be considered before and during immunosuppressive therapy. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Joint deformity, disability, osteoporosis, infection and increased cardiovascular risk.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
OSTEOPOROSIS
Skeletal disorder of low bone strength that increases fragility fracture risk.
Skeletal disorder of low bone strength that increases fragility fracture risk.
Osteoporosis is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Ageing, menopause, low body weight, family history, glucocorticoid exposure, endocrine disease, malabsorption and inactivity contribute.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Bone resorption exceeds bone formation, reducing bone mass and altering microarchitecture. Fragility fractures occur when weakened bone fails under forces that would not normally cause fracture.
- Usually silent until a fragility fracture; vertebral fractures may cause height loss, kyphosis and back pain.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
DXA bone-density testing, fracture-risk assessment and laboratory evaluation for secondary causes when appropriate.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Adequate calcium/vitamin D intake, weight-bearing/resistance activity, fall prevention and anti-osteoporosis medicines such as bisphosphonates or other agents according to fracture risk.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess falls and home hazards; reinforce safe weight-bearing exercise; teach medication administration precautions; support adequate nutrition; monitor after fragility fracture and encourage adherence.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Skeletal disorder of low bone strength that increases fragility fracture risk.
- Assess fracture risk, falls, vitamin D/calcium status and adherence to bone-protective therapy.
- New back pain or height loss can indicate vertebral compression fracture.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Osteomalacia, metastatic disease and other metabolic bone disorders may produce bone pain or fractures. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Assess fracture risk, falls, vitamin D/calcium status and adherence to bone-protective therapy. New back pain or height loss can indicate vertebral compression fracture. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hip, vertebral and wrist fractures, chronic pain, disability and loss of independence.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
BONE FRACTURE
Break in bone continuity caused by trauma, repetitive stress or weakened bone.
Break in bone continuity caused by trauma, repetitive stress or weakened bone.
Bone Fracture is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Falls, road/occupational trauma, sports injury, osteoporosis, tumour or stress injury.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
A fracture disrupts cortical and/or trabecular bone and may injure surrounding vessels, nerves and soft tissue. Healing proceeds through inflammation, callus formation and remodelling, but can be impaired by poor blood supply, infection or instability.
- Pain, swelling, deformity, bruising and loss of function.
- Open fractures communicate with the external environment.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
X-rays in at least two views; CT/MRI for selected complex or occult injuries; neurovascular examination is essential.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Reduction and immobilisation, analgesia, operative fixation for selected fractures, tetanus and antibiotics for open fractures, and rehabilitation.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Perform repeated distal neurovascular checks; support and elevate the limb as prescribed; monitor cast/splint pressure and pain; use compartment-syndrome warning signs; provide pin/wound care and DVT prevention according to plan.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Break in bone continuity caused by trauma, repetitive stress or weakened bone.
- Repeated distal neurovascular assessment is essential.
- Pain out of proportion, tense swelling or worsening neurological findings can indicate compartment syndrome.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Severe soft-tissue injury or dislocation may mimic fracture, but imaging confirms bone injury. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Repeated distal neurovascular assessment is essential. Pain out of proportion, tense swelling or worsening neurological findings can indicate compartment syndrome. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Compartment syndrome, neurovascular injury, infection, DVT, delayed/non-union and fat embolism syndrome.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
OSTEOMYELITIS
Infection of bone, which may be acute or chronic and can arise haematogenously, from contiguous spread or direct inoculation.
Infection of bone, which may be acute or chronic and can arise haematogenously, from contiguous spread or direct inoculation.
Osteomyelitis is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Staphylococcus aureus is common; gram-negative and other organisms vary with age, exposure, surgery and comorbidity.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Micro-organisms invade bone via blood, contiguous spread or direct inoculation. Inflammation raises intramedullary pressure and can compromise blood flow, causing necrotic bone that shelters bacteria and promotes chronic infection.
- Local bone pain, tenderness, swelling, fever and sometimes a draining sinus in chronic disease.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Inflammatory markers, blood cultures, MRI and bone/tissue culture for definitive microbiological diagnosis when possible.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Prolonged targeted antimicrobial therapy and surgical debridement/drainage when necrotic bone, abscess or hardware infection requires it.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Obtain cultures before antibiotics when ordered; monitor pain, fever and wound/drainage; perform sterile wound care; monitor IV access and antimicrobial toxicity; support nutrition and mobility restrictions.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Infection of bone, which may be acute or chronic and can arise haematogenously, from contiguous spread or direct inoculation.
- Monitor fever, pain, wound drainage, inflammatory markers and antimicrobial toxicity.
- Chronic sinus tracts or persistent infection may require surgical debridement.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Bone tumour, inflammatory arthritis and cellulitis may cause local pain and swelling. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor fever, pain, wound drainage, inflammatory markers and antimicrobial toxicity. Chronic sinus tracts or persistent infection may require surgical debridement. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Chronic infection, pathological fracture, sepsis and impaired growth/function.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PRE-ECLAMPSIA / ECLAMPSIA
Pregnancy-specific hypertensive disorder after 20 weeks with new hypertension plus proteinuria and/or maternal organ dysfunction. Eclampsia is the occurrence of seizures attributable to pre-eclampsia.
Pregnancy-specific hypertensive disorder after 20 weeks with new hypertension plus proteinuria and/or maternal organ dysfunction. Eclampsia is the occurrence of seizures attributable to pre-eclampsia.
Pre-eclampsia / Eclampsia is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Abnormal placentation and maternal endothelial dysfunction are central; risk rises with previous pre-eclampsia, multifetal pregnancy, chronic hypertension, kidney disease and some autoimmune conditions.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Abnormal placentation and widespread maternal endothelial dysfunction cause vasoconstriction, increased vascular permeability and organ injury. Severe disease may affect the brain, liver, kidneys, placenta and coagulation system. Eclampsia refers to seizures attributable to pre-eclampsia.
- Hypertension, headache, visual symptoms, epigastric/right upper quadrant pain, oedema, reduced urine output and laboratory abnormalities; seizures define eclampsia.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Repeated BP measurement, urine protein assessment, full blood count/platelets, liver and renal tests, and fetal surveillance.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Definitive treatment is delivery at a gestation/timing balancing maternal and fetal risk. Severe hypertension requires urgent antihypertensive therapy; magnesium sulfate is used for seizure treatment/prophylaxis in severe disease according to protocol.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Frequent BP and neurological assessment; monitor urine output, reflexes and respiratory rate during magnesium therapy; seizure precautions and low-stimulation environment; fetal monitoring; prepare for urgent delivery if deterioration occurs.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Pregnancy-specific hypertensive disorder after 20 weeks with new hypertension plus proteinuria and/or maternal organ dysfunction.
- Eclampsia is the occurrence of seizures attributable to pre-eclampsia.
- Frequent blood pressure, neurological symptoms, reflexes, urine output, platelets, liver/renal tests and fetal surveillance are required.
- Severe headache, visual disturbance, epigastric pain or reduced urine output are warning signs.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
Chronic hypertension, gestational hypertension, migraine, epilepsy and other causes of liver or renal dysfunction may overlap. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Frequent blood pressure, neurological symptoms, reflexes, urine output, platelets, liver/renal tests and fetal surveillance are required. Severe headache, visual disturbance, epigastric pain or reduced urine output are warning signs. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Eclampsia, stroke, HELLP syndrome, placental abruption, fetal growth restriction, preterm birth and maternal organ failure.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
POSTPARTUM HAEMORRHAGE
Excessive postpartum bleeding, clinically important because rapid blood loss can cause shock. Primary PPH usually occurs within 24 hours of birth.
Excessive postpartum bleeding, clinically important because rapid blood loss can cause shock. Primary PPH usually occurs within 24 hours of birth.
Postpartum Haemorrhage is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- The four Ts: Tone (uterine atony), Trauma, Tissue retained in uterus and Thrombin/coagulopathy.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
PPH most commonly results from uterine atony, but trauma, retained tissue and coagulopathy are also major causes. Continued bleeding rapidly reduces circulating volume and tissue perfusion, and massive haemorrhage can precipitate DIC.
- Heavy vaginal bleeding, boggy enlarged uterus with atony, tachycardia, hypotension, pallor, dizziness and shock.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Clinical diagnosis with rapid assessment; full blood count, coagulation studies and crossmatch while identifying the source.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Immediate uterine massage for atony, uterotonic medicines, tranexamic acid within recommended timing, IV fluids/blood products and escalation to balloon tamponade, surgery or interventional radiology as required.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Call obstetric emergency team; quantify blood loss; uterine massage when indicated; establish/maintain large-bore IV access; frequent vital signs and shock assessment; administer uterotonics/fluids/blood as prescribed; keep patient warm and document events precisely.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Excessive postpartum bleeding, clinically important because rapid blood loss can cause shock.
- Primary PPH usually occurs within 24 hours of birth.
- Quantify blood loss, assess uterine tone, pulse, blood pressure, mental state, urine output and coagulation.
- Ongoing bleeding despite initial measures requires rapid escalation.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
The source of bleeding must be identified quickly using the four-T framework: Tone, Trauma, Tissue and Thrombin. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Quantify blood loss, assess uterine tone, pulse, blood pressure, mental state, urine output and coagulation. Ongoing bleeding despite initial measures requires rapid escalation. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Hypovolaemic shock, DIC, acute kidney injury, Sheehan syndrome, hysterectomy and death.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
PELVIC INFLAMMATORY DISEASE
Ascending infection/inflammation of the upper female genital tract involving endometrium, fallopian tubes, ovaries and adjacent pelvic structures.
Ascending infection/inflammation of the upper female genital tract involving endometrium, fallopian tubes, ovaries and adjacent pelvic structures.
Pelvic Inflammatory Disease is best understood by first relating it to normal musculoskeletal & reproductive physiology. The condition becomes clinically important when the underlying disturbance is severe enough to impair organ function, reduce physiological reserve, or create a risk of acute deterioration. Nurses should therefore assess both the named disorder and the patient’s overall physiological response.
- Often associated with sexually transmitted pathogens such as Chlamydia trachomatis and Neisseria gonorrhoeae, but infection is frequently polymicrobial.
- Risk assessment should separate non-modifiable background factors from modifiable exposures and immediate precipitants.
- This distinction is important because long-term prevention often depends on controlling modifiable risk, whereas acute management focuses on reversing the precipitating factor and stabilising physiology.
Micro-organisms ascend from the lower genital tract into the endometrium, fallopian tubes and adjacent pelvic structures. Inflammation can scar the tubes, increasing later infertility and ectopic pregnancy risk.
- Lower abdominal/pelvic pain, abnormal vaginal discharge or bleeding, dyspareunia, fever and cervical motion/adnexal tenderness.
- Assessment should include onset, duration, severity, progression, aggravating and relieving factors, associated symptoms, previous episodes, medication history, allergies, comorbidities and functional impact.
- Findings should be trended rather than documented as isolated observations because deterioration is often recognised through change over time.
Pregnancy test, STI testing, urinalysis and pelvic ultrasound when abscess or alternative diagnosis is suspected.
Investigations should answer three questions: Does the patient truly have this condition? How severe is it? Is there an underlying cause or complication that changes management? Results should be interpreted alongside the clinical picture rather than in isolation. Serial testing may be more informative than a single value, particularly in acute illness.
Prompt broad-spectrum antibiotics covering likely pathogens; severe illness, pregnancy or tubo-ovarian abscess may require hospital care and specialist management.
Medical treatment is directed at stabilising immediate physiological threats, treating the underlying cause, relieving symptoms, preventing complications and reducing recurrence. Therapy should be individualised for age, pregnancy status, renal and hepatic function, comorbid disease, drug interactions, allergy history and local guideline recommendations. Escalation to specialist, procedural, surgical or critical-care management is required when organ dysfunction is severe or conservative treatment fails.
Assess pain, fever and pregnancy status; obtain specimens before antibiotics when ordered without delaying treatment; reinforce completing therapy, partner evaluation/treatment and abstaining from sexual contact until treatment criteria are met; monitor for abscess/sepsis.
Nursing management should be organised around assessment, intervention, reassessment and escalation. The nurse is responsible for recognising changes in condition early, delivering prescribed therapy safely, preventing avoidable complications and coordinating communication within the multidisciplinary team.
- Ascending infection/inflammation of the upper female genital tract involving endometrium, fallopian tubes, ovaries and adjacent pelvic structures.
- Monitor pain, fever and signs of tubo-ovarian abscess or sepsis.
- Pregnancy testing is essential because ectopic pregnancy must not be missed.
- Reassessment should occur after every significant intervention and whenever symptoms change.
- The frequency of observations should match the patient’s acuity.
- Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Ectopic pregnancy, appendicitis, ovarian torsion, UTI and endometriosis may mimic PID. A safe clinical approach avoids assuming that every symptom in a patient with a known diagnosis is caused by that diagnosis; concurrent illness and time-critical mimics must still be considered.
- Assess pain, mobility, swelling, skin integrity and distal neurovascular status where limb injury is present. Rationale: Establishes a reliable baseline and allows early recognition of deterioration.
- Support safe mobilisation, prescribed immobilisation and falls prevention while maintaining as much function as possible. Rationale: Supports physiological stability and reduces avoidable stress on the affected organ system.
- Use sterile wound or pin-site care where indicated and monitor for infection. Rationale: Ensures prescribed treatment is delivered safely and that benefit or harm is recognised promptly.
- In obstetric emergencies, prioritise maternal ABC, quantify blood loss, monitor fetal/maternal status and follow emergency protocols. Rationale: Identifies complications before they become clinically advanced.
- Administer prescribed analgesia, anti-inflammatory, uterotonic, antimicrobial or disease-modifying therapy and reassess response. Rationale: Reduces preventable hospital complications and supports recovery.
- Provide rehabilitation, joint/bone health or reproductive-health education appropriate to the diagnosis. Rationale: Improves adherence, self-management and timely help-seeking after discharge.
Monitor pain, fever and signs of tubo-ovarian abscess or sepsis. Pregnancy testing is essential because ectopic pregnancy must not be missed. Reassessment should occur after every significant intervention and whenever symptoms change. The frequency of observations should match the patient’s acuity. Deterioration should be escalated using the institution’s early-warning or emergency-response pathway rather than waiting for the next routine review.
Follow mobility, exercise, joint-protection, wound or obstetric instructions as prescribed; use assistive devices safely; keep follow-up appointments; and seek urgent care for neurovascular compromise, severe swelling, fever, heavy vaginal bleeding, seizure, or sudden severe headache/visual symptoms.
Education should be delivered in clear language and should cover the purpose of medicines, important adverse effects, follow-up requirements, lifestyle measures, warning symptoms and when to seek urgent help. Teach-back is useful for confirming understanding, especially when the plan is complex.
Infertility, ectopic pregnancy, chronic pelvic pain and tubo-ovarian abscess.
Prognosis depends on disease severity, speed of diagnosis, reversibility of the cause, comorbidity and response to treatment. Preventing recurrence and detecting complications early are central parts of nursing follow-up.
Clinical priority: Use an ABCDE approach for acute deterioration. New shock, severe respiratory distress, major bleeding, prolonged seizure, sudden focal neurological deficit, severe chest pain, rapidly falling consciousness or other life-threatening change requires immediate escalation according to local emergency protocols.
- Acute pain
- Impaired physical mobility
- Risk for peripheral neurovascular dysfunction
- Risk for infection
- Risk for deficient fluid volume
Desired outcomes include controlled pain, preserved neurovascular function, safe mobility, absence of infection and stabilisation of any obstetric emergency. Evaluation should document whether planned outcomes were achieved, partially achieved or not achieved, and should identify what changes to the care plan are required.
General & Systemic Pathology
Core mechanisms of disease that explain the structural and functional changes encountered in medical–surgical nursing.
Chapter 65 — Cellular Adaptation, Injury and Cell Death
Cellular homeostasis and adaptation
Normal cells maintain a relatively stable internal environment despite changes in workload, nutrient supply and hormonal stimulation. When demands increase, cells may adapt rather than immediately become injured. Major adaptive responses include hypertrophy, hyperplasia, atrophy and metaplasia. Hypertrophy is an increase in cell size, as seen in skeletal muscle after exercise or left-ventricular hypertrophy in chronic hypertension. Hyperplasia is an increase in cell number and occurs in tissues capable of division. Atrophy is a reduction in cell size and sometimes cell number because of reduced workload, denervation, poor nutrition, loss of endocrine stimulation or ageing. Metaplasia is replacement of one mature cell type by another that tolerates stress better, but persistent metaplasia can predispose to dysplasia and malignancy.
Reversible cell injury
Cells become injured when stress exceeds their adaptive capacity. Common causes include hypoxia, ischaemia, toxins, infection, immune reactions, nutritional imbalance, physical injury and genetic abnormalities. Early injury reduces ATP production, disrupts ion pumps and causes cellular swelling. Fatty change is especially important in organs involved in lipid metabolism, such as the liver. If the harmful stimulus is removed at this stage, the cell may return to normal.
Irreversible injury and cell death
Severe or prolonged injury causes irreversible mitochondrial dysfunction and major membrane damage. Necrosis is uncontrolled cell death associated with membrane rupture, enzyme leakage and inflammation. Patterns include coagulative necrosis in many solid-organ infarcts, liquefactive necrosis in brain infarction and abscesses, caseous necrosis in tuberculosis, fat necrosis in pancreatitis and fibrinoid necrosis in immune-mediated vascular injury. Apoptosis is regulated cell death that removes unwanted or damaged cells with much less surrounding inflammation.
Chapter 66 — Inflammation, Infection and Tissue Repair
Acute inflammation
Acute inflammation is a rapid protective response to infection or tissue injury. Vasodilation increases local blood flow, while increased vascular permeability allows plasma proteins and leukocytes to leave the circulation. Neutrophils are prominent early effector cells in many bacterial infections. The classic local features—redness, heat, swelling, pain and loss of function—reflect these vascular and cellular changes.
Systemic inflammatory responses may cause fever, tachycardia, increased white-cell production and acute-phase protein synthesis. When the host response to infection becomes dysregulated and organ dysfunction develops, the syndrome is sepsis rather than uncomplicated local inflammation.
Chronic inflammation
Chronic inflammation persists when the injurious agent cannot be eliminated or when immune regulation is abnormal. Macrophages, lymphocytes and plasma cells predominate. Persistent inflammation can cause tissue destruction at the same time that repair and fibrosis occur. Tuberculosis, chronic viral hepatitis, rheumatoid arthritis and inflammatory bowel disease demonstrate different forms of chronic inflammation.
Healing and wound repair
Repair proceeds through haemostasis, inflammation, proliferation and remodelling. Platelets and clotting factors first control bleeding. Inflammatory cells remove debris and microbes. Fibroblasts then produce extracellular matrix and collagen, while angiogenesis restores blood supply and epithelial cells migrate across the wound. Collagen is reorganised during remodelling, increasing tensile strength over time.
Healing is delayed by infection, tissue hypoxia, poor perfusion, diabetes, protein-calorie malnutrition, glucocorticoid exposure, foreign bodies and repeated mechanical stress. Nursing wound assessment should therefore document wound size, depth, tissue type, exudate, odour, surrounding skin, pain and systemic infection signs.
Chapter 67 — Oedema, Thrombosis, Embolism, Infarction and Shock
Oedema
Oedema results from abnormal movement of fluid into the interstitial space. Mechanisms include increased hydrostatic pressure, reduced plasma oncotic pressure, increased vascular permeability, lymphatic obstruction and sodium retention. Heart failure commonly increases venous hydrostatic pressure, while severe hypoalbuminaemia in nephrotic syndrome or cirrhosis reduces oncotic pressure.
Thrombosis and embolism
Thrombus formation is explained by Virchow’s triad: endothelial injury, abnormal blood flow and hypercoagulability. A venous thrombus can detach and travel to the pulmonary circulation, causing pulmonary embolism. Arterial thrombosis is often associated with atherosclerosis and can cause myocardial infarction, stroke or limb ischaemia.
Infarction
An infarct is an area of ischaemic necrosis caused by interruption of arterial supply or venous drainage. The clinical effect depends on the tissue, collateral circulation, duration of obstruction and oxygen requirement. Brain and myocardium are especially sensitive to interruption of blood flow.
Shock
Shock is a state of inadequate tissue perfusion. Hypovolaemic shock follows major fluid or blood loss; cardiogenic shock follows severe pump failure; distributive shock includes septic and anaphylactic shock; and obstructive shock may occur with massive pulmonary embolism or tension pneumothorax. Regardless of type, persistent hypoperfusion causes cellular hypoxia, lactate accumulation, organ dysfunction and eventually irreversible injury.
Chapter 68 — Neoplasia and Cancer Biology
Neoplasia is autonomous abnormal cell proliferation caused by accumulated genetic and epigenetic changes. Benign tumours remain localised, whereas malignant tumours invade surrounding tissues and may metastasise through lymphatic, blood or body-cavity pathways.
Hallmarks of malignant behaviour
- Persistent proliferative signalling and reduced response to growth suppression.
- Resistance to programmed cell death.
- Ability to replicate repeatedly and stimulate new blood-vessel formation.
- Invasion, tissue destruction and metastatic spread.
- Metabolic reprogramming and evasion of immune destruction.
Grading and staging
Grade describes how abnormal tumour cells appear microscopically and how closely they resemble the tissue of origin. Stage describes the anatomical extent of disease. TNM systems commonly assess primary tumour extent, regional lymph-node involvement and distant metastasis. Staging is usually more important than grade for prognosis in many solid tumours.
Nursing implications
Nursing care includes symptom control, nutritional support, infection and bleeding prevention, central-line care, psychosocial support, safe handling of hazardous medicines, monitoring for treatment toxicity and prompt recognition of oncological emergencies such as neutropenic sepsis, tumour lysis syndrome, spinal cord compression and superior vena cava obstruction.
Chapter 69 — Immunopathology
Immune disease may arise from excessive responses, inappropriate targeting of self-antigens or inadequate host defence. Hypersensitivity reactions are commonly grouped into four mechanisms. Type I reactions are immediate and IgE mediated; type II reactions involve antibodies directed against cell-surface or matrix antigens; type III reactions involve immune-complex deposition; and type IV reactions are primarily T-cell mediated.
Autoimmune disease develops when self-tolerance fails. Genetic susceptibility, environmental triggers and altered immune regulation contribute to disorders such as systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid disease. Immunodeficiency may be primary or acquired; HIV infection is an important acquired cause.
Clinical Microbiology & Infection Prevention
Organisms, specimens, transmission, antimicrobial susceptibility and infection-control principles relevant to nursing practice.
Chapter 70 — Foundations of Medical Microbiology
Host–microbe relationship
The presence of a microorganism does not always mean infection. Colonisation refers to organisms living on or in the body without causing tissue injury, while infection implies invasion or multiplication associated with a host response and clinical disease. Contamination refers to accidental introduction of organisms into a specimen or surface. Distinguishing these concepts prevents unnecessary antimicrobial treatment.
Virulence
Virulence is the ability of an organism to cause disease. Virulence factors include capsules that resist phagocytosis, toxins, enzymes that promote tissue invasion, adherence structures and mechanisms that evade immune recognition. Disease severity reflects both the organism and the host’s immune status.
Microbiology studies organisms capable of causing human disease, including bacteria, viruses, fungi and parasites. Infection occurs when an organism enters the host, multiplies and causes tissue injury or a harmful immune response. Colonisation means an organism is present without producing disease; this distinction is important because colonisation does not automatically require antimicrobial treatment.
Bacterial structure and classification
Bacteria are prokaryotic cells. Clinically useful classification includes Gram reaction, shape, oxygen requirement and biochemical characteristics. Gram-positive organisms retain crystal violet and appear purple; Gram-negative organisms possess an outer membrane and appear pink after counterstaining. Cocci are spherical and bacilli are rod shaped. Some bacteria, such as Mycobacterium tuberculosis, require special stains because of their lipid-rich cell walls.
Viruses
Viruses contain DNA or RNA enclosed in protein and sometimes a lipid envelope. They require living host cells for replication. Antibacterial drugs do not treat viral infections. Antiviral therapy targets specific stages of viral replication and therefore differs markedly between virus families.
Fungi and parasites
Fungi include yeasts and moulds. Superficial fungal disease is common, but invasive fungal infection is especially important in patients with neutropenia, organ transplantation, prolonged intensive-care admission or major immunosuppression. Parasites include protozoa and helminths; malaria remains one of the most clinically important protozoal infections worldwide.
Chapter 71 — Specimen Collection and Laboratory Diagnosis
Why specimen quality matters
Laboratory accuracy depends heavily on pre-analytical quality. A specimen from the wrong site, collected after prolonged antibiotic exposure or contaminated during collection may produce misleading results. Nurses therefore play a direct role in diagnostic accuracy by selecting the correct container, using aseptic technique, collecting adequate volume, labelling correctly and ensuring timely transport.
Accurate microbiological diagnosis begins before the specimen reaches the laboratory. The correct specimen must come from the correct anatomical site, be collected using appropriate aseptic technique and reach the laboratory in a suitable container within the recommended time.
Blood culture
Important nursing principles
Obtain before antibiotics when this will not delay urgent treatment; use strict skin antisepsis; collect the prescribed volume and number of sets.
Common errors
Contamination from poor skin preparation, inadequate volume, drawing all bottles from one line.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Urine
Important nursing principles
Use clean-catch midstream collection where appropriate; obtain catheter specimens from the sampling port rather than the drainage bag.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common errors
Contamination, prolonged standing at room temperature, incorrect container.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Sputum
Important nursing principles
Encourage a deep cough from the lower respiratory tract; collect before antibiotics when possible.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common errors
Submitting saliva rather than sputum.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
CSF
Important nursing principles
Handle urgently; correct tube labelling and rapid transport are essential.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common errors
Delay in transport, mislabelling.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Wound/tissue
Important nursing principles
Deep tissue or aspirate is often more informative than a superficial swab; follow local collection policy.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common errors
Swabbing colonised surface material only.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Culture and susceptibility testing
Culture identifies organisms able to grow under laboratory conditions. Susceptibility testing estimates whether an antimicrobial is likely to inhibit the isolated organism at clinically achievable concentrations. The final choice of therapy still depends on infection site, patient factors, pharmacokinetics and local guidelines.
Chapter 72 — Important Bacterial Pathogens
Staphylococcus aureus
Major clinical associations
Skin infection, wound infection, bacteraemia, endocarditis, osteomyelitis and pneumonia.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Observe wounds and vascular devices carefully; resistant strains may require additional contact precautions according to policy.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Streptococcus pneumoniae
Major clinical associations
Pneumonia, meningitis, otitis and invasive bloodstream infection.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Respiratory assessment, vaccination awareness and prompt recognition of meningitis/sepsis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Escherichia coli
Major clinical associations
UTI, intra-abdominal infection, sepsis and several diarrhoeal syndromes.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Safe catheter care and appropriate urine specimen collection.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Klebsiella pneumoniae
Major clinical associations
Pneumonia, UTI and healthcare-associated bloodstream infection.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Antimicrobial resistance can be substantial; infection-control compliance is critical.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Pseudomonas aeruginosa
Major clinical associations
Hospital pneumonia, burns/wounds, UTI and infection in immunocompromised patients.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Often resistant to multiple drugs; careful device and wound care reduces risk.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Neisseria meningitidis
Major clinical associations
Meningitis and meningococcaemia.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Urgent droplet precautions and public-health contact management according to protocol.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mycobacterium tuberculosis
Major clinical associations
Pulmonary and extrapulmonary tuberculosis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Airborne precautions for infectious pulmonary/laryngeal disease and strict treatment adherence.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Clostridioides difficile
Major clinical associations
Antibiotic-associated diarrhoea and colitis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Nursing / infection-control relevance
Contact precautions, soap-and-water hand hygiene after care and sporicidal environmental cleaning.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Chapter 73 — Important Viruses
Clinically important viruses include influenza viruses, respiratory syncytial virus, SARS-CoV-2, hepatitis viruses, HIV, herpesviruses, measles virus and several arboviruses. Transmission may be respiratory, faeco-oral, blood-borne, sexual, vector-borne or vertical from mother to child.
Nursing responsibilities include correct transmission-based precautions, vaccination education, safe sharps practice, confidentiality, specimen collection and recognition of complications. Viral infections often require supportive care, while specific antiviral therapy is used only where an effective agent exists for the particular virus.
Chapter 74 — Parasitology
Malaria
Malaria is caused by Plasmodium species transmitted mainly by infected female Anopheles mosquitoes. Parasites first multiply in hepatocytes and later infect red blood cells. P. falciparum can cause severe disease through high parasite burden and sequestration of infected erythrocytes in the microcirculation.
Helminths
Important helminth infections include schistosomiasis, soil-transmitted helminthiasis and filarial disease. Prevention depends heavily on water, sanitation, vector control, footwear or other exposure-reduction strategies depending on the organism.
Chapter 75 — Infection Prevention, Isolation and Antimicrobial Stewardship
Breaking the chain of infection
Infection transmission can be interrupted at several points: elimination or control of the infectious agent, treatment of reservoirs, containment of portals of exit, interruption of transmission, protection of portals of entry and reduction of host susceptibility through measures such as vaccination and good nutrition.
Hand hygiene remains one of the most effective measures in healthcare infection prevention. The correct method and timing depend on clinical activity and whether visibly soiled hands or spore-forming organisms are involved.
Standard precautions
Standard precautions apply to every patient and include hand hygiene, appropriate personal protective equipment, respiratory hygiene, safe injection practice, sharps safety, environmental cleaning and correct handling of linen and waste.
Transmission-based precautions
Contact precautions are added for organisms spread mainly by direct or indirect contact; droplet precautions reduce transmission through larger respiratory particles; and airborne precautions are required for pathogens capable of remaining suspended in air, such as infectious pulmonary tuberculosis.
Antimicrobial stewardship
Stewardship aims to achieve the best clinical outcome while reducing toxicity, resistance and unnecessary antimicrobial exposure. Nurses contribute by obtaining cultures correctly, administering antibiotics on time, checking allergies, monitoring response and toxicity, documenting indication and duration, and supporting de-escalation when culture results permit.
Pharmacology for Nurses
Mechanisms, therapeutic uses, adverse effects, contraindications, interactions and nursing responsibilities across the major drug groups.
Chapter 76 — General Pharmacology
Pharmacokinetics: what the body does to a drug
Pharmacokinetics describes absorption, distribution, metabolism and excretion. Absorption is movement from the administration site into the systemic circulation. Distribution depends on blood flow, protein binding and tissue permeability. Metabolism commonly occurs in the liver through phase I and phase II reactions. Excretion is usually renal but may also occur through bile, lungs or other routes.
Bioavailability is the fraction of an administered dose reaching systemic circulation unchanged. Half-life is the time required for plasma concentration to decrease by half under defined conditions. Steady state is usually approached after several half-lives during repeated dosing.
Pharmacodynamics: what a drug does to the body
Drugs may act as receptor agonists, partial agonists, antagonists, enzyme inhibitors, ion-channel modulators or through physicochemical mechanisms. Potency refers to the amount of drug needed to produce a given effect, whereas efficacy refers to the maximum effect the drug can produce.
Medication safety
- Confirm patient identity using approved identifiers.
- Verify the medicine, indication, dose, route, timing and allergy status.
- Check renal/hepatic function and relevant interactions when required.
- Perform independent double checks for high-alert medicines according to policy.
- Document administration and reassess therapeutic response and adverse effects.
- Never conceal a medication error; recognise, report and manage it promptly according to institutional policy.
Chapter 77 — Autonomic Pharmacology
Principles of autonomic drug action
The autonomic nervous system regulates involuntary functions such as heart rate, vascular tone, bronchial calibre, gastrointestinal motility, glandular secretion and bladder function. Drugs may either mimic autonomic neurotransmitters, increase their availability or block their receptors. Understanding the receptor involved is essential because the same medicine can have therapeutic effects in one organ and unwanted effects in another.
Sympathetic effects are mediated mainly through alpha and beta adrenergic receptors. Alpha-1 stimulation produces vasoconstriction, beta-1 stimulation increases heart rate and contractility, and beta-2 stimulation relaxes bronchial smooth muscle. Parasympathetic effects are mediated mainly through muscarinic receptors and include slowing of the heart, increased secretions and contraction of smooth muscle in several organs.
Beta-adrenergic agonists
Examples
Salbutamol/albuterol. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Main action
Beta-2 stimulation relaxes bronchial smooth muscle.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common clinical uses
Bronchospasm in asthma and COPD.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Monitor respiratory response, tremor, heart rate and inhaler technique.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Beta blockers
Examples
Metoprolol, bisoprolol, propranolol. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Main action
Block beta-adrenergic effects.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common clinical uses
Selected cardiovascular conditions, rate control and other indications.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Check pulse and blood pressure; abrupt withdrawal may be harmful; bronchospasm risk varies by selectivity.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Antimuscarinics
Examples
Ipratropium, atropine. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Main action
Block muscarinic acetylcholine receptors.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common clinical uses
Bronchodilation, selected bradyarrhythmias and other indications.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Dry mouth, urinary retention and tachycardia may occur.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Alpha-1 blockers
Examples
Prazosin, doxazosin. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Main action
Reduce alpha-1-mediated vasoconstriction.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Common clinical uses
Hypertension and selected urinary symptoms.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Orthostatic hypotension and first-dose dizziness are important.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Chapter 78 — Cardiovascular Pharmacology
General principles
Cardiovascular medicines alter vascular resistance, circulating volume, myocardial contractility, heart rate, electrical conduction or thrombus formation. Because these medicines directly affect perfusion, nurses should always evaluate blood pressure, pulse, renal function, electrolytes and symptoms such as dizziness, chest pain, breathlessness or bleeding before and after administration when clinically relevant.
ACE inhibitors and angiotensin-receptor blockers
These medicines reduce the effects of the renin–angiotensin–aldosterone system. They are commonly used in hypertension, heart failure and selected patients with chronic kidney disease. Important adverse effects include hypotension, worsening renal function and hyperkalaemia. ACE inhibitors can cause cough and, rarely, angioedema. They are contraindicated in pregnancy.
Calcium-channel blockers
Dihydropyridine agents such as amlodipine mainly reduce vascular smooth-muscle tone and therefore lower blood pressure. Non-dihydropyridine agents such as verapamil and diltiazem also slow atrioventricular conduction and reduce heart rate. Nursing monitoring includes blood pressure, pulse, oedema and, with rate-limiting agents, bradycardia or heart block.
Antihypertensive medicines
Major groups include ACE inhibitors, angiotensin-receptor blockers, calcium-channel blockers, thiazide/thiazide-like diuretics, beta blockers and other agents selected according to comorbidity and guideline recommendations. Nurses monitor blood pressure, orthostatic symptoms, renal function and electrolytes according to the drug used.
Heart-failure therapy
Modern heart-failure management may combine renin–angiotensin system modulation, evidence-based beta blockade, mineralocorticoid receptor antagonism, SGLT2 inhibition and diuretics for congestion. The exact regimen depends on ejection fraction, renal function, potassium, blood pressure and clinical status.
Antiplatelet and anticoagulant medicines
Antiplatelet agents reduce platelet activation and are important in acute coronary syndromes and secondary atherosclerotic prevention. Anticoagulants reduce coagulation-cascade activity and are used in venous thromboembolism and selected patients with atrial fibrillation. The principal nursing hazard is bleeding; renal function, interactions and procedural plans are also important.
Chapter 79 — Respiratory Pharmacology
Bronchodilator therapy
Bronchodilators reduce reversible airway narrowing by relaxing bronchial smooth muscle. Short-acting beta-2 agonists provide rapid relief of bronchospasm, whereas long-acting beta agonists and long-acting muscarinic antagonists are used for maintenance in selected patients. Correct inhaler technique is as important as the medicine itself because poor technique can result in little drug reaching the lower airways.
Anti-inflammatory therapy
Inhaled corticosteroids suppress airway inflammation and are central to long-term asthma control. They do not provide immediate relief of acute bronchospasm. Local adverse effects include dysphonia and oral candidiasis, which can be reduced by correct technique and mouth rinsing. Systemic corticosteroids are reserved for selected exacerbations and other inflammatory conditions because systemic adverse effects increase with dose and duration.
Short-acting beta-2 agonists
Examples
Salbutamol/albuterol. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Role
Rapid bronchodilation.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Important adverse effects / monitoring
Tremor, tachycardia and hypokalaemia at high exposure.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Long-acting bronchodilators
Examples
LABA and LAMA agents. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Role
Maintenance bronchodilation in selected asthma/COPD regimens.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Important adverse effects / monitoring
Inhaler technique and adherence are essential.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Inhaled corticosteroids
Examples
Budesonide, beclometasone, fluticasone. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Role
Reduce airway inflammation.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Important adverse effects / monitoring
Oral candidiasis and dysphonia; rinse mouth after use.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Systemic corticosteroids
Examples
Prednisolone, hydrocortisone. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Role
Acute inflammatory exacerbations and other indications.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Important adverse effects / monitoring
Hyperglycaemia, mood change, infection risk and GI effects; prolonged therapy should not be stopped suddenly.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Chapter 80 — Antimicrobial Pharmacology
Choosing an antimicrobial
The appropriate antimicrobial depends on the suspected pathogen, site of infection, severity of illness, local resistance pattern, allergy history, renal and hepatic function, pregnancy status and previous microbiology results. Broad empiric therapy may be necessary in severe illness, but treatment should be reviewed once culture or molecular results are available.
Resistance and stewardship
Antimicrobial resistance develops when organisms survive drug exposure and resistant populations are selected. Unnecessary prescribing, subtherapeutic exposure and poor adherence contribute to resistance. Nurses support stewardship by obtaining specimens correctly, documenting allergies accurately, administering doses on time, monitoring clinical response and adverse effects, and encouraging completion of an appropriate prescribed course.
Principles
Empiric antimicrobial treatment is chosen before the exact organism is known and should reflect the likely source, severity and local resistance pattern. Definitive treatment is narrowed once culture or molecular results identify the pathogen and susceptibility pattern.
Penicillins
Examples
Amoxicillin, flucloxacillin and others. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Inhibit bacterial cell-wall synthesis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
Verify allergy history; monitor rash, diarrhoea and anaphylaxis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Cephalosporins
Examples
Cefuroxime, ceftriaxone and others. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Inhibit cell-wall synthesis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
Allergy assessment, renal considerations and antimicrobial stewardship.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Macrolides
Examples
Azithromycin, clarithromycin. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Inhibit bacterial protein synthesis at the 50S ribosome.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
GI effects and QT-related interactions may be relevant.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Aminoglycosides
Examples
Gentamicin, amikacin. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Bind the 30S ribosomal subunit and disrupt protein synthesis.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
Nephrotoxicity and ototoxicity; therapeutic monitoring may be required.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Fluoroquinolones
Examples
Ciprofloxacin and others. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Inhibit bacterial DNA gyrase/topoisomerase.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
Multiple important adverse effects and interactions; use should follow guideline indications.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Antituberculous therapy
Examples
Rifampicin, isoniazid, pyrazinamide, ethambutol. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Mechanism
Combination therapy targets different mycobacterial processes.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Major nursing issues
Adherence, hepatotoxicity monitoring, drug interactions and visual monitoring with ethambutol.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Chapter 81 — CNS, Analgesic and Sedative Pharmacology
Analgesic pharmacology
Analgesic choice should be matched to the type and severity of pain. Paracetamol/acetaminophen is useful for many mild-to-moderate pain states and fever. NSAIDs reduce prostaglandin synthesis and are especially useful when inflammation contributes to pain, but they can impair renal perfusion, irritate the gastrointestinal mucosa and influence cardiovascular risk. Opioids provide potent analgesia but can cause sedation, respiratory depression, nausea, constipation and dependence.
Antiseizure medicines
Antiseizure medicines reduce abnormal neuronal excitability through different mechanisms. Selection depends on seizure type, comorbidities, pregnancy potential, interaction profile and adverse-effect risk. Nurses should monitor adherence, cognition, mood, rash and drug-specific laboratory parameters where required. Sudden discontinuation can precipitate seizures.
Analgesics include paracetamol/acetaminophen, NSAIDs and opioids. NSAIDs reduce prostaglandin synthesis and can cause gastrointestinal, renal and cardiovascular adverse effects. Opioids act predominantly at opioid receptors and may cause sedation, respiratory depression, constipation, nausea and dependence.
Antiseizure medicines use several mechanisms, including modulation of sodium or calcium channels and enhancement of inhibitory neurotransmission. Selection depends on seizure type, patient factors and interaction profile. Abrupt discontinuation can precipitate seizures.
Sedatives and anaesthetic agents can suppress airway reflexes and ventilation. Nursing care includes sedation scoring, airway assessment, respiratory monitoring, haemodynamic observation and readiness to escalate deterioration.
Chapter 82 — Endocrine Pharmacology
Insulin and glucose-lowering therapy
Insulin lowers blood glucose by increasing cellular glucose uptake and suppressing hepatic glucose production and ketogenesis. Preparations differ in onset, peak and duration. Hypoglycaemia is the most important acute nursing risk. Other glucose-lowering agents act by improving insulin sensitivity, increasing glucose-dependent insulin release, reducing renal glucose reabsorption or altering gastrointestinal and glucagon physiology.
Thyroid and adrenal therapy
Levothyroxine replaces deficient thyroid hormone and should be taken consistently because absorption is influenced by food and interacting medicines. Antithyroid medicines suppress thyroid-hormone synthesis in selected hyperthyroid patients. Glucocorticoids have both replacement and pharmacological anti-inflammatory roles; prolonged therapy suppresses the hypothalamic–pituitary–adrenal axis, so abrupt discontinuation can be dangerous.
Insulin
Insulin preparations differ in onset and duration of action. Nursing care includes accurate dose verification, coordination with food when appropriate, glucose monitoring, recognition of hypoglycaemia, correct storage and injection-site rotation.
Oral and injectable glucose-lowering medicines
Metformin decreases hepatic glucose production and improves insulin sensitivity. SGLT2 inhibitors increase urinary glucose excretion and provide important cardio-renal benefits in selected patients. GLP-1 receptor agonists improve glucose-dependent insulin secretion, reduce glucagon and slow gastric emptying. Other classes are used according to individual requirements.
Thyroid and adrenal medicines
Levothyroxine replaces thyroid hormone in hypothyroidism. Antithyroid medicines reduce thyroid-hormone synthesis in selected hyperthyroid patients. Glucocorticoids replace cortisol in adrenal insufficiency and are also used pharmacologically for their anti-inflammatory effects; prolonged therapy requires careful tapering rather than abrupt withdrawal.
Chapter 83 — Obstetric and Emergency Pharmacology
Important obstetric medicines include uterotonics such as oxytocin, agents used for hypertensive emergencies in pregnancy and magnesium sulfate for seizure prophylaxis/treatment in severe pre-eclampsia or eclampsia according to protocol. Emergency medicines include adrenaline/epinephrine for anaphylaxis and resuscitation, glucose therapies for hypoglycaemia, anticonvulsants for prolonged seizures, and vasoactive drugs in critical care.
Paediatric Nursing, Medicines & Drug Calculations
Assessment, common childhood conditions, paediatric pharmacology, safe medicine administration and calculation methods used in nursing practice.
Chapter 84 — Principles of Paediatric Nursing
Children are not simply small adults. Body-water distribution, renal clearance, hepatic enzyme activity, airway anatomy, cardiovascular reserve and communication needs change with age and development. Paediatric nursing therefore combines physiological assessment with developmental, family and safeguarding considerations.
Assessment
- Observe appearance, interaction, tone, consolability and work of breathing before touching the child when possible.
- Interpret heart rate, respiratory rate and blood pressure against age-appropriate reference ranges used by the institution.
- Assess hydration through mucous membranes, tears, urine output, capillary refill, skin and overall clinical behaviour.
- Measure weight accurately because many medicines and fluids are prescribed according to weight.
- Use age-appropriate pain scales and communication techniques.
- Include parents or caregivers as partners while maintaining the child’s dignity and safeguarding responsibilities.
Medication safety in children
Paediatric dosing often depends on kilograms of body weight or body-surface area. Decimal errors can cause large relative overdoses in small children. Weight should be documented in kilograms, not pounds, and high-risk calculations should be independently checked according to local policy.
Chapter 85 — Essential Neonatal Nursing
Immediate priorities after birth
Newborn care focuses on establishing breathing, maintaining temperature, supporting feeding, preventing infection and recognising congenital or perinatal problems. Newborns lose heat rapidly because of their large surface-area-to-mass ratio and limited thermal reserve.
Prematurity
Preterm infants are vulnerable to respiratory distress, apnoea, temperature instability, feeding difficulty, infection, jaundice, intraventricular haemorrhage and necrotising enterocolitis. Care may include thermoregulation, respiratory support, careful fluid and nutritional management, infection prevention and developmental care.
Neonatal jaundice
Unconjugated bilirubin commonly rises after birth because neonatal bilirubin production is high while hepatic conjugation is immature. Pathological jaundice may occur because of haemolysis, infection, metabolic disease or other causes. Excessive unconjugated bilirubin can enter the brain and cause bilirubin encephalopathy, so bilirubin must be interpreted according to postnatal age, gestation and risk factors.
Chapter 86 — Common Paediatric Respiratory Conditions
Acute respiratory infection and pneumonia
Children with pneumonia may present with cough, fever, tachypnoea, increased work of breathing, feeding difficulty or hypoxaemia. Nursing priorities are airway and breathing assessment, oxygen when indicated, hydration, appropriate antimicrobial administration when bacterial pneumonia is diagnosed or strongly suspected, fever management and repeated reassessment.
Bronchiolitis
Bronchiolitis is usually viral and predominantly affects infants. Small-airway oedema, mucus and cellular debris cause wheeze, crackles and increased work of breathing. Management is primarily supportive: hydration, nasal care and oxygen/respiratory support when needed. Routine antibiotics do not treat uncomplicated viral bronchiolitis.
Asthma
Paediatric asthma involves variable bronchoconstriction and airway inflammation. Acute management uses bronchodilator therapy and anti-inflammatory treatment according to severity, while long-term control depends on inhaled corticosteroid-containing regimens, trigger management and correct spacer/inhaler technique.
Chapter 87 — Diarrhoea, Vomiting and Dehydration
Acute gastroenteritis can cause rapid fluid and electrolyte loss in children. Severity should be assessed from general appearance, mental state, thirst/feeding, pulse, capillary refill, urine output and other signs rather than a single feature.
Oral rehydration solution is the foundation of treatment for children able to drink and without severe shock. Intravenous isotonic fluid is used when severe dehydration, shock or inability to tolerate enteral replacement makes oral therapy inadequate. Ongoing feeding and breastfeeding should usually continue according to the clinical plan.
Chapter 88 — Malaria, Sepsis, Meningitis and Febrile Illness
Malaria
Paediatric malaria can progress rapidly to severe anaemia, hypoglycaemia, seizures, acidosis or impaired consciousness, particularly with P. falciparum. Confirm parasitaemia with appropriate testing when feasible and treat according to severity and national/WHO protocols.
Sepsis
Children with sepsis may initially maintain blood pressure despite impaired perfusion. Changes in mental state, capillary refill, pulse quality, temperature, respiratory effort and urine output can be important warning signs. Management is time critical and includes antimicrobial therapy, circulatory support and source control according to paediatric protocols.
Meningitis
Infants may have nonspecific manifestations such as poor feeding, irritability, lethargy, temperature instability or seizures rather than classic neck stiffness. Suspected bacterial meningitis requires urgent medical assessment and prompt antimicrobial treatment.
Chapter 89 — Malnutrition and Growth Disorders
Child growth should be interpreted using age- and sex-appropriate growth standards. Acute and chronic undernutrition increase infection risk, impair development and reduce physiological reserve. Severe acute malnutrition requires careful assessment because aggressive fluid or electrolyte therapy can be harmful in certain clinical circumstances.
Nursing management includes anthropometric measurement, feeding assessment, temperature and glucose monitoring, infection surveillance, skin care, careful prescribed nutritional rehabilitation and family education.
Chapter 90 — Paediatric Haematology
Anaemia
Iron deficiency is common in childhood but anaemia may also result from haemoglobinopathies, infection, nutritional deficiency, chronic disease or blood loss. Investigation depends on age, clinical context, full blood count indices and additional tests.
Sickle cell disease
Children with sickle cell disease require vaccination, infection prevention, pain management, hydration when appropriate, screening for complications and disease-modifying therapy according to specialist protocols. Fever requires prompt assessment because functional asplenia greatly increases the risk of invasive bacterial infection.
Chapter 91 — Paediatric Renal Disorders
Common renal problems include UTI, nephrotic syndrome, glomerulonephritis and acute kidney injury. In nephrotic syndrome, heavy proteinuria causes hypoalbuminaemia and oedema. In post-infectious glomerulonephritis, haematuria, oedema and hypertension may develop after infection. Accurate blood pressure, weight and urine-output monitoring are especially important.
Chapter 92 — Paediatric Medicines
Why paediatric pharmacology is different
Drug absorption, distribution, metabolism and elimination change throughout infancy and childhood. Total body water is proportionally higher in neonates and infants, plasma-protein binding differs, hepatic enzyme systems mature over time and glomerular filtration is lower in early life. These physiological differences mean that simply reducing an adult dose is unsafe.
Paediatric prescribing should therefore use a current age-appropriate reference and the child’s current weight, indication and organ function. The nurse should confirm whether the prescription is expressed per dose or per day, check the maximum permitted dose, verify the available concentration and use an independent double check for high-alert medicines.
Medication administration to children
Oral medicines should be measured using an oral syringe or another accurate device rather than household spoons. When IV medicines are used, the final concentration and infusion rate must be verified carefully because small errors represent a large proportional dose in infants. Whenever possible, medicines should be explained to the child in developmentally appropriate language and caregivers should be taught how to administer them safely at home.
Paracetamol / acetaminophen
Common paediatric role
Analgesia and fever-related discomfort.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Check all combination products to avoid duplicate exposure; verify weight-based prescribed dose and maximum daily exposure.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Ibuprofen and other NSAID therapy
Common paediatric role
Pain and inflammation in selected children.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Assess hydration, renal disease, GI bleeding risk and age/indication restrictions.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Amoxicillin / penicillin-class antibiotics
Common paediatric role
Selected bacterial respiratory, ENT and other infections.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Confirm allergy, indication and weight-based order; monitor rash, diarrhoea and clinical response.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Ceftriaxone and other cephalosporins
Common paediatric role
Serious bacterial infection according to local protocol.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Check allergy history, age-specific restrictions, renal/hepatic considerations and compatibility.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Gentamicin / aminoglycosides
Common paediatric role
Serious gram-negative or neonatal infections in selected protocols.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Precise weight-based prescribing, renal monitoring and therapeutic drug monitoring where required.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Salbutamol / albuterol
Common paediatric role
Bronchodilation in asthma/wheeze.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Assess respiratory response, tremor, heart rate and device/spacer technique.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Inhaled corticosteroids
Common paediatric role
Controller therapy in persistent asthma.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Teach spacer technique and mouth rinsing; monitor symptom control and adherence.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Systemic corticosteroids
Common paediatric role
Selected acute inflammatory conditions.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Monitor glucose, infection and GI effects; prolonged courses require tapering per prescriber plan.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Artemisinin-based antimalarial therapy
Common paediatric role
Uncomplicated falciparum malaria according to national protocols.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Confirm diagnostic testing where required, weight-based prescribed regimen and treatment completion.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Parenteral artesunate
Common paediatric role
Severe malaria in hospital protocols.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Urgent administration per protocol; monitor glucose, haemoglobin, consciousness and organ function.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Benzodiazepines
Common paediatric role
Emergency treatment of prolonged seizures according to protocol.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Airway and respiratory monitoring are essential; use protocol-specific route and concentration.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Adrenaline / epinephrine
Common paediatric role
Anaphylaxis and resuscitation.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Concentration and route errors are dangerous; follow the paediatric emergency chart and independent-check policy.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Oral rehydration solution
Common paediatric role
Replacement of water and electrolytes in diarrhoeal dehydration.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
Give according to dehydration plan; continue reassessment and feeding as clinically appropriate.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Insulin
Common paediatric role
Type 1 diabetes and selected acute metabolic emergencies.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Key nursing considerations
High-alert medicine: independent check, glucose monitoring, coordination with meals/IV fluids and hypoglycaemia preparedness.. This point should be interpreted in the context of the patient’s diagnosis, age, comorbidities, current observations and local clinical guidance.
Chapter 93 — Paediatric Drug Calculations
Dimensional analysis and unit conversion
Many calculation errors begin with units. Before calculating, convert all quantities to compatible units. One gram equals 1000 milligrams and one milligram equals 1000 micrograms. Weight must be recorded in kilograms. If a prescription is written in micrograms and the stock is labelled in milligrams, the units must be converted before dividing.
Checking whether the answer is reasonable
A mathematically correct calculation can still be clinically wrong if the prescription itself is inappropriate. After calculating, compare the result with the recognised paediatric dose range, maximum dose, expected volume and practical administration method. An unusually large or very small volume should trigger rechecking of the dose, concentration and units before administration.
Calculation skill does not replace clinical verification. Before calculating, confirm that the prescription is complete, the child’s current weight is recorded in kilograms, allergies are known, the medicine and concentration match the order, and the prescribed amount falls within an accepted paediatric reference range.
1. Basic liquid medicine calculation
Worked example — arithmetic only
A prescription states 180 mg. The supplied liquid contains 120 mg in 5 mL.
Volume = (180 ÷ 120) × 5 = 7.5 mL.
This example demonstrates the calculation only; the prescribed 180 mg is not a recommended clinical dose.
2. Weight-based prescribed amount
Worked example — arithmetic only
An authorised order states 15 mg/kg/dose for a child weighing 12 kg.
Amount per dose = 15 × 12 = 180 mg per dose.
The nurse must still verify that the ordered mg/kg value is appropriate for that drug, indication and child using the current formulary.
3. mg/kg/day divided into several doses
Amount per dose = total daily amount ÷ number of doses per day
Worked example — arithmetic only
An authorised prescription states 30 mg/kg/day divided into 3 equal doses for a 20 kg child.
Total daily amount = 30 × 20 = 600 mg/day.
Each dose = 600 ÷ 3 = 200 mg per dose.
4. Body-surface area calculation
Some specialist medicines are prescribed in mg/m² rather than mg/kg. One commonly taught method of estimating BSA is the Mosteller equation.
Worked example — BSA only
Height = 120 cm; weight = 24 kg.
BSA = √[(120 × 24) ÷ 3600] = √0.8 ≈ 0.89 m².
If a specialist order is written in mg/m², multiply the authorised mg/m² value by the calculated BSA and independently verify the result.
5. IV infusion rate
Worked example
A prescribed 240 mL infusion is to run over 6 hours.
240 ÷ 6 = 40 mL/hour.
6. Gravity infusion rate
Worked example
Volume = 100 mL, time = 60 minutes, giving set = 20 drops/mL.
(100 × 20) ÷ 60 = 33.3, therefore approximately 33 drops/minute when the local policy permits gravity administration and rounding in this way.
7. Reconstitution and concentration
After reconstitution, always use the final concentration stated by the manufacturer or pharmacy rather than assuming the diluent volume equals the final volume.
8. Maintenance fluid calculation
A commonly taught hourly maintenance method is the 4–2–1 rule: 4 mL/kg/hour for the first 10 kg, 2 mL/kg/hour for the next 10 kg, and 1 mL/kg/hour for each kilogram above 20 kg. The final prescribed fluid type and rate must be clinically authorised.
Worked example — maintenance calculation only
For a 25 kg child: first 10 kg = 40 mL/h; next 10 kg = 20 mL/h; remaining 5 kg = 5 mL/h. Total = 65 mL/hour.
Medication-calculation safety checklist
- Use the current measured weight in kilograms.
- Read the complete prescription, including units and frequency.
- Check whether the order is per dose or per day.
- Compare the ordered mg/kg or mg/m² value with an authoritative paediatric formulary.
- Check maximum-dose limits where applicable.
- Confirm stock concentration and final concentration after reconstitution.
- Use a leading zero for values below 1 (for example, 0.5 mg) and never use a trailing zero (write 5 mg, not 5.0 mg).
- Independently double-check high-alert medicines according to policy.
- If the result looks unusual, stop and clarify before administration.
Chapter 94 — Paediatric Emergencies
Respiratory distress
Children can deteriorate rapidly because their airways are smaller and respiratory reserve is limited. Signs of severe distress include marked recession, grunting, cyanosis, exhaustion, poor air entry, altered consciousness and falling oxygen saturation. Airway support, oxygen and escalation should follow paediatric emergency protocols.
Shock
Tachycardia and peripheral vasoconstriction may precede hypotension. Capillary refill, pulse quality, mental status, urine output and respiratory pattern are therefore important in early recognition.
Prolonged seizure
Protect the child from injury, support airway and breathing, check glucose and administer prescribed first-line anticonvulsant therapy according to the paediatric emergency protocol. Continued seizure activity requires rapid escalation.
Anaphylaxis
Intramuscular adrenaline/epinephrine is first-line treatment for anaphylaxis. Because paediatric emergency doses are weight based and concentration errors can be dangerous, nurses should use the current emergency chart rather than memory alone.
Integrated Pathology, Microbiology, Pharmacology and Paediatrics
Additional chapters deepen the scientific concepts that support clinical nursing reasoning.
Chapter 95 — Fluid, Electrolyte and Acid–Base Pathology
Body-fluid compartments
Total body water is distributed between intracellular and extracellular compartments. The extracellular compartment includes plasma and interstitial fluid. Sodium is the major extracellular cation and strongly influences extracellular osmolality and volume, whereas potassium is the major intracellular cation and is essential for membrane excitability.
Sodium disorders
Hyponatraemia usually represents excess water relative to sodium rather than simple sodium deficiency. Symptoms are primarily neurological because rapid falls in extracellular osmolality cause cerebral oedema. Hypernatraemia represents a relative water deficit and can cause intense thirst, weakness, confusion, seizures and coma. The rate of correction matters because overly rapid osmotic change can itself injure the brain.
Potassium disorders
Hypokalaemia increases the risk of weakness, ileus and cardiac arrhythmia. Hyperkalaemia can produce life-threatening conduction abnormalities. Nurses should interpret potassium together with kidney function, acid–base status, medications and haemolysis of the specimen. Severe abnormalities require urgent ECG assessment and protocol-based management.
Acid–base balance
Arterial pH is determined mainly by the relationship between carbon dioxide, regulated through ventilation, and bicarbonate, regulated largely by the kidneys. Primary respiratory disorders change carbon dioxide; primary metabolic disorders change bicarbonate. Compensation reduces but does not normally overcorrect the primary disturbance. Clinical interpretation should combine pH, carbon dioxide, bicarbonate, anion gap and the patient’s history.
Chapter 96 — Genetic and Molecular Basis of Disease
Human disease may result from single-gene mutations, chromosomal abnormalities, mitochondrial inheritance or complex interaction between multiple genes and environmental exposure. A mutation may alter protein structure, enzyme activity, receptor function or gene regulation. Some variants are pathogenic, whereas others are benign or of uncertain significance.
Autosomal dominant disorders often appear in successive generations, while autosomal recessive disorders may occur in siblings born to unaffected carrier parents. X-linked disorders show characteristic sex-related inheritance patterns. Multifactorial diseases such as hypertension, type 2 diabetes and many cancers reflect combined genetic susceptibility and environment rather than a single mutation.
Chapter 97 — Host Defence and the Immune Response to Infection
Physical and chemical barriers
Intact skin, mucus, ciliary clearance, gastric acid, normal microbiota and antimicrobial secretions form the first line of defence. Devices such as urinary catheters, central lines and endotracheal tubes bypass these barriers and therefore increase infection risk.
Innate immunity
Innate immune cells recognise conserved microbial structures and respond quickly. Neutrophils phagocytose many bacteria and fungi; macrophages ingest organisms and coordinate inflammation; natural killer cells target infected or abnormal cells; and complement promotes opsonisation, inflammation and membrane injury.
Adaptive immunity
B lymphocytes differentiate into antibody-producing plasma cells, while T lymphocytes coordinate cell-mediated immunity. Immunological memory explains why vaccination can provide faster and stronger responses on later exposure.
Chapter 98 — Antimicrobial Resistance
Microorganisms may resist antimicrobials through drug-destroying enzymes, altered drug targets, reduced permeability, active efflux or alternative metabolic pathways. Resistance genes can arise by mutation or move between bacteria through mobile genetic elements.
Resistance becomes clinically important when standard therapy no longer reliably treats an infection. Nurses help reduce resistance by ensuring cultures are collected correctly, antimicrobials are administered at the prescribed interval, unnecessary doses are not given, allergies are documented accurately and infection-prevention measures are followed.
Colonisation versus infection
Resistant organisms can colonise a patient without causing disease. Treating colonisation unnecessarily exposes the patient to adverse effects and further selection pressure. The decision to treat must therefore consider symptoms, site, specimen quality and clinical evidence of infection.
Chapter 99 — Sterilisation, Disinfection and Aseptic Practice
Sterilisation destroys all forms of microbial life, including bacterial spores. Disinfection reduces or eliminates many pathogenic organisms on inanimate objects but does not always destroy spores. Antisepsis refers to antimicrobial treatment of living tissue such as skin.
The level of reprocessing required depends on how an item is used. Critical items that enter sterile tissue require sterilisation. Semi-critical items contacting mucous membranes require high-level disinfection or sterilisation according to device guidance. Non-critical items contacting intact skin require appropriate cleaning and lower-level disinfection.
Aseptic technique prevents introduction of pathogenic organisms during invasive procedures and device manipulation. It depends on hand hygiene, clean or sterile equipment as appropriate, protection of key parts and sites, and minimising unnecessary manipulation.
Chapter 100 — Adverse Drug Reactions and Drug Interactions
Adverse drug reactions
An adverse drug reaction is an unintended harmful response to a medicine used at normal therapeutic exposure. Predictable reactions arise from the known pharmacology of a drug, while unpredictable reactions include immune-mediated allergy and certain idiosyncratic responses. Severity ranges from mild nausea to anaphylaxis, organ failure or life-threatening skin reactions.
Drug–drug interactions
Pharmacokinetic interactions alter absorption, distribution, metabolism or excretion. Pharmacodynamic interactions alter the combined physiological effect without necessarily changing concentrations. Examples include additive sedation, increased bleeding or excessive blood-pressure lowering. Polypharmacy, older age, kidney disease and liver disease increase interaction risk.
Nursing responsibilities
Review the full medication list, including non-prescription and herbal products. Confirm allergy history carefully and distinguish true allergy from predictable intolerance. Report suspected serious adverse reactions through the appropriate pharmacovigilance system and document them clearly to prevent re-exposure.
Chapter 101 — Medicines in Kidney and Liver Dysfunction
Kidney disease can reduce elimination of medicines or active metabolites, increasing toxicity. Dose adjustment may involve reducing the amount per dose, increasing the interval or both. Renal replacement therapies can remove some drugs and may require supplemental dosing under specialist protocols.
Liver disease can alter first-pass metabolism, protein binding, drug activation and clearance. In advanced cirrhosis, reduced albumin and altered hepatic blood flow can make drug response less predictable. Sedatives, opioids and nephrotoxic medicines require particular caution because they can precipitate encephalopathy, respiratory depression or kidney injury.
Chapter 102 — Gastrointestinal Pharmacology
Acid-suppressive medicines
Proton-pump inhibitors suppress gastric acid secretion by irreversibly inhibiting the gastric proton pump. They are used for peptic ulcer disease, reflux disease and selected prevention of upper gastrointestinal bleeding. Long-term use should have a continuing indication because chronic exposure is associated with several potential adverse effects and drug interactions.
Antiemetics
Antiemetics act through serotonin, dopamine, histamine, muscarinic or neurokinin pathways depending on the medicine. Selection depends on the cause of nausea and patient factors. Nurses should consider sedation, extrapyramidal effects, QT prolongation, constipation and anticholinergic effects where relevant.
Laxatives and antidiarrhoeal agents
Laxatives include bulk-forming, osmotic, stimulant and stool-softening agents. The correct choice depends on the cause of constipation and comorbidity. Antimotility agents may relieve selected uncomplicated diarrhoea but should be avoided in certain invasive infections or severe colitis.
Chapter 103 — Haematology Pharmacology
Anticoagulants
Anticoagulants reduce coagulation and are used to prevent or treat thromboembolic disease. Heparins, vitamin K antagonists and direct oral anticoagulants differ in onset, elimination, interactions and monitoring. Bleeding is the principal complication, but thrombosis can occur if therapy is interrupted inappropriately.
Antiplatelet medicines
Aspirin and P2Y12 inhibitors reduce platelet activation and are central to management of atherosclerotic cardiovascular disease in selected patients. Nurses should monitor for bleeding and understand when temporary interruption requires specialist direction.
Haematinics
Iron, folate and vitamin B12 correct deficiency when the diagnosis is established. Giving replacement without identifying the cause can delay recognition of gastrointestinal bleeding, malabsorption or another important disorder.
Chapter 104 — Growth and Development
Paediatric nursing requires understanding of normal growth and developmental progression. Growth describes measurable physical change such as weight, length/height and head circumference, while development describes acquisition of motor, language, cognitive, social and adaptive skills.
Development is influenced by genetics, nutrition, chronic disease, stimulation, family environment and social determinants of health. Milestones are ranges rather than exact deadlines, but loss of previously acquired skills is always concerning and warrants assessment.
Developmentally appropriate care
Infants rely heavily on caregivers for regulation and comfort. Toddlers need simple choices and reassurance. School-age children benefit from concrete explanations, and adolescents should be included directly in decisions with age-appropriate privacy and confidentiality. Pain assessment tools should match developmental ability.
Chapter 105 — Paediatric Cardiac Disorders
Congenital heart disease ranges from small defects with minimal physiological effect to complex lesions causing cyanosis, heart failure or duct-dependent circulation in the neonatal period. Clinical features can include poor feeding, sweating with feeds, tachypnoea, poor weight gain, recurrent respiratory infection, cyanosis or a murmur.
Left-to-right shunts
Atrial septal defect, ventricular septal defect and patent ductus arteriosus may cause increased pulmonary blood flow. Large shunts can produce heart failure and pulmonary vascular disease.
Cyanotic lesions
Right-to-left shunting allows deoxygenated blood to enter systemic circulation. Tetralogy of Fallot is a classic example. Acute worsening of cyanosis requires calm handling, oxygen and emergency management according to the child’s cardiac plan.
Nursing care
Monitor feeding tolerance, weight gain, respiratory effort, oxygen saturation and signs of heart failure. Cluster care to reduce energy expenditure and support nutritional plans. Families often require detailed education before discharge after cardiac procedures.
Chapter 106 — Paediatric Neurological Disorders
Neurological illness in children may present differently from adults because developmental stage affects communication and examination. Seizures, meningitis, hydrocephalus, cerebral palsy and neuromuscular disorders are important conditions in paediatric practice.
Febrile seizures
Febrile seizures occur in young children with fever and usually have a good prognosis. The priority is to protect the child from injury, assess airway and breathing, determine seizure duration and identify serious causes of fever. A prolonged seizure requires emergency anticonvulsant management.
Hydrocephalus
Hydrocephalus results from abnormal accumulation of cerebrospinal fluid, causing ventricular enlargement and potentially raised intracranial pressure. Infants may develop increasing head circumference, bulging fontanelle or downward gaze. Older children may present with headache, vomiting or visual symptoms.
Chapter 107 — Paediatric Endocrine and Metabolic Disorders
Paediatric endocrine disease affects growth, pubertal development, glucose regulation and metabolism. Type 1 diabetes is one of the most important chronic endocrine disorders in children and requires lifelong insulin, glucose monitoring and family education.
Diabetic ketoacidosis in children
Paediatric DKA requires particularly careful fluid, electrolyte and neurological monitoring because cerebral injury is a feared complication. Treatment should follow a paediatric DKA protocol rather than adult assumptions. Changes in headache, behaviour, consciousness, heart rate or blood pressure during treatment require urgent reassessment.
Growth disorders
Abnormal growth may result from nutritional deficiency, chronic systemic disease, thyroid disease, growth-hormone disorders or genetic conditions. Serial growth measurements plotted correctly are more informative than a single height or weight.
Chapter 108 — Safe Paediatric Medication Practice
Every paediatric medication administration should begin with a current weight in kilograms and a complete authorised prescription. The nurse must determine whether the dose is written per kilogram per dose, per kilogram per day, by body-surface area or as a fixed dose. The calculation should then be compared with an authoritative paediatric formulary and any maximum-dose limit.
Concentration errors
Many paediatric medicines are available in more than one concentration. A correct milligram dose can become a dangerous volume error if the wrong concentration is selected. The medication label should therefore be read at preparation and again before administration. Reconstituted medicines must use the manufacturer’s final concentration rather than assumptions about the volume of diluent added.
High-alert medicines
Insulin, opioids, concentrated electrolytes, anticoagulants, sedatives and emergency medicines require additional safeguards. Independent double checks, smart-pump libraries and standardised concentrations reduce error where available. If the calculated dose or volume appears unusual, administration should stop until the prescription is clarified.
Reference Framework and Further Reading
This textbook is designed around standard principles used in international nursing and medical education. For clinical practice, readers should consult the most recent institutional policies, national treatment guidelines and recognised formularies because recommendations, antimicrobial resistance patterns and medicine indications can change.
Core reference families
- World Health Organization guidance on communicable disease, antimicrobial stewardship, maternal and child health, malaria and tuberculosis.
- National and institutional treatment protocols applicable to the reader’s country and clinical setting.
- Recognised adult and paediatric medicines formularies for dose, contraindication, interaction and monitoring verification.
- Current cardiovascular, respiratory, renal, endocrine, neurological and obstetric specialty guidelines.
- Standard pathology, microbiology, pharmacology, medical–surgical nursing and paediatric nursing textbooks.